Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
<< vorige   
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             1764 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1001 LGI3 associates with astroglial response against Abeta and accumulates in aged monkey brains Okabayashi, Sachi
2009
5 4S p. P222
artikel
1002 Lifetime Diet And Cognitive Performance In An Older Community-dwelling Population Hosking, Diane E.
2009
5 4S p. e22
artikel
1003 Light therapy for managing symptoms of dementia: A cochrane review Forbes, Dorothy A.
2009
5 4S p. P408
artikel
1004 Linking molecular genetics and neuropathology at the MAPT locus Wade-Martins, Richard
2009
5 4S p. P169
artikel
1005 Links between cerebral atrophy, behavioral alterations, and neuropathological changes in mouse lemur primates Dhenain, Marc
2009
5 4S p. P179
artikel
1006 Links between cerebral atrophy, behavioral alterations and neuropathological changes in mouse lemur primates Dhenain, Marc
2009
5 4S p. P7
artikel
1007 Lipid-dependent production of neurotoxic Abeta protofibrils from fibrils Rousseau, Frederic
2009
5 4S p. P120
artikel
1008 Lipoxygenase mediated intracellular oxidative stress regulates Aβ42 production Saxena, Uday
2009
5 4S p. P312
artikel
1009 Live cell imaging of β-secretase activity in SH-SY5Y cells Packard, Beverly Z.
2009
5 4S p. P477
artikel
1010 Live cell imaging of β-secretase activity in SH-SY5Y cells Packard, Beverly Z.
2009
5 4S p. P44
artikel
1011 Living free of dementia to age 90 Kuller, Lewis H.
2009
5 4S p. P386-P387
artikel
1012 Lobar distribution of cerebral microbleeds: The Rotterdam Scan Study Poels, Mariëlle M.F.
2009
5 4S p. P32
artikel
1013 Lobar distribution of cerebral microbleeds: The Rotterdam scan study Poels, Mariëlle M.F.
2009
5 4S p. P203
artikel
1014 Localization of tau in rough endoplasmic reticulum and the mechanism of neurodegeneration Leclerc, Nicole M.
2009
5 4S p. P92-P93
artikel
1015 Longevity genotype is associated with a reduced rate of memory decline and reduced incidence of dementia: Results from the Einstein Aging Study Lipton, Richard B.
2009
5 4S p. P471
artikel
1016 Longitudinal measure of IVIG treatment effect in patients with Alzheimer's and Lewy Body disease Shankle, William R.
2009
5 4S p. P430
artikel
1017 Longitudinal medication usage in Alzheimer's disease patients Zhu, Carolyn W.
2009
5 4S p. P407
artikel
1018 Longitudinal study of amyloid deposition in carriers of presenilin-1, presenilin-2 and APP mutations Klunk, William E.
2009
5 4S p. P368-P369
artikel
1019 Longitudinal study of amyloid deposition in carriers of presenilin-1, presenilin-2 and APP mutations Klunk, William E.
2009
5 4S p. P26
artikel
1020 Longitudinal study on plasma amyloid beta (Aβ) 42 and late-onset depression: Concept of amyloid-associated depression weakened Blasko, Imrich
2009
5 4S p. P380
artikel
1021 Long-term effect of history of coronary artery bypass grafting surgery (CABG) on cognitive diagnosis, MRI findings and episodic memory scores Duara, Ranjan
2009
5 4S p. P387-P388
artikel
1022 Long-term effect of phenserine treatment in Alzheimer patients as assessed by PET and CSF biomarkers Kadir, Ahmadul
2009
5 4S p. P6
artikel
1023 Long-term effects of simvastatin and atorvastatin on a rat model of normal brain aging Searcy, James L.
2009
5 4S p. P335
artikel
1024 Long-term in vivo imaging identifies multiple events that trigger dendritic spine loss in 3xTg-AD mice Bittner, Tobias
2009
5 4S p. P438
artikel
1025 Loose membrane-bound endogenous factors might modulates the intramembrane cleavages of βAPP Mori, Kohji
2009
5 4S p. P474
artikel
1026 Loss of NPC1 leads to decreased expression of APP at the cell surface and alters APP distribution within endosome compartments Lisica, Ana
2009
5 4S p. P301
artikel
1027 Lost in the mist: alzheimer's and abuse Hatcher, Robin T.
2009
5 4S p. P228
artikel
1028 Low activity of angiotensin-converting enzyme (ACE) is a risk factor for onset of Alzheimer's disease Akatsu, Hiroyasu
2009
5 4S p. P280
artikel
1029 Lower body mass index associated with higher CSF levels of tau pathology in Alzheimer's Disease Ewers, Michael
2009
5 4S p. P284
artikel
1030 Lymphocytes from Alzheimer's disease patients display alterations in the cell cycle Kuzniewska, Bozena
2009
5 4S p. P312
artikel
1031 Magnetic Resonance Spectroscopy (MRS) analysis in Alzheimer's disease: A novel approach for integrating metabolite spectra, tissue segmentation and perfusion data Szilagyi, Gregory
2009
5 4S p. P52-P53
artikel
1032 Magnetic Resonance Spectroscopy (MRS) analysis in Alzheimer's disease - a novel approach for integrating metabolite spectra, tissue segmentation and perfusion data Szilagyi, Gregory
2009
5 4S p. P216
artikel
1033 Major considerations in conducting a global phase III registration study in Alzheimer's disease Mohs, Richard C.
2009
5 4S p. P170
artikel
1034 Mammillary body atrophy in the differential diagnosis of hippocampal atrophy Murray, Melissa E.
2009
5 4S p. P108
artikel
1035 Marine neuroprotectants activating the alpha-secretase pathway: A novel approach for the treatment of Alzheimer's disease Dominguez, Juan M.
2009
5 4S p. P425
artikel
1036 MARK4 and its involvement in phosphorylating tau at Ser262 in rat primary neurons Moore, Jennifer
2009
5 4S p. P398
artikel
1037 Markers of Alzheimer's disease in a naturalistic population attending a memory clinic Prestia, Annapaola
2009
5 4S p. P342
artikel
1038 Mass buildup of soluble oligomeric Aß40 occurs in sporadic Alzheimer's disease Halliday, Glenda M.
2009
5 4S p. P302
artikel
1039 Measurement of amyloid-beta production and clearance directly in humans Bateman, Randall J.
2009
5 4S p. P94
artikel
1040 Measurement of cerebrospinal fluid total tau and phospho-tau in phase 2 trials of therapies targeting Aβ Siemers, Eric R.
2009
5 4S p. P258
artikel
1041 Measurement of episodic memory using word tasks in Roman and non-Roman alphabet languages: Validation from a multicentre clinical trial Wesnes, Keith A.
2009
5 4S p. P457
artikel
1042 Measurement of grey matter water diffusion in the clinical variants of frontotemporal lobar degeneration and Alzheimer's disease Whitwell, Jennifer L.
2009
5 4S p. P20
artikel
1043 Measuring progression of Alzheimer's disease with imaging: Outcome measures for trials? Jack, Clifford R.
2009
5 4S p. P72
artikel
1044 Mechanism of carnitine's protection for tau hyperphosphorylation caused by homocysteine Guo, Ziyuan
2009
5 4S p. P337
artikel
1045 Mechanism of the effects of nicotine on Alzheimer's disease Zhao, Baolu
2009
5 4S p. P413
artikel
1046 Mechanism underlying apolipoprotein E (ApoE) isoform-dependent HDL generation and impairment of ApoE3-mediated HDL generation by homocysteine Minagawa, Hirohisa
2009
5 4S p. P306
artikel
1047 Medical and Scientific Advisory Council 2009
5 4S p. A7
artikel
1048 Melatonin attenuates aβ amyloidosis induce tau hyperphosphorylation in transgenic mice Tg2576 of different ages Peng, Caixia
2009
5 4S p. P441
artikel
1049 Melatonin potentiates neuroprotective property of resveratrol through heme oxygenase-1 induction Han, Seol-Heui
2009
5 4S p. P336-P337
artikel
1050 Memantine in Alzheimer's disease - results of an observational study in nursing home patients Riepe, Matthias W.
2009
5 4S p. P249
artikel
1051 Memantine reverses ß-amyloid oligomers-induced deficits in long term potentiation (LTP) in murine hippocampal slices Parsons, Christopher G.
2009
5 4S p. P176
artikel
1052 Membrane proteins and Aβ peptide toxicity Manzoni, Claudia
2009
5 4S p. P490-P491
artikel
1053 Memogain; supra-bioavailable nicotinic enhancer for the treatment of Alzheimer's disease Maelicke, Alfred
2009
5 4S p. P326
artikel
1054 Memory connection investigation using diffusion tensor imaging Zhou, Yongxia
2009
5 4S p. P55-P56
artikel
1055 Memory groups: Improving memory knowledge, satisfaction and functioning of healthy elderly Lymperopoulou, Olga
2009
5 4S p. P238
artikel
1056 Memory impairment in the Tg6590 transgenic rat model of Alzheimer's disease Benedikz, Eirikur
2009
5 4S p. P443
artikel
1057 Memory loss in young APPswe/PS1dE9 mice and associated changes in brain metabolism analyzed using a 3D voxel-based approach Hérard, Anne-Sophie
2009
5 4S p. P209
artikel
1058 Memory loss in young APPswe/PS1dE9 mice and associated changes in brain metabolism analyzed using a 3-D voxel-based approach Hérard, Anne-Sophie
2009
5 4S p. P8-P9
artikel
1059 Merging amyloid-beta cascade and activity-dependent plasticity in hippocampus: A possible role for ADAM10 Marcello, Elena
2009
5 4S p. P475
artikel
1060 Meta-analysis of CSF biomarkers in mild cognitive impairment patients: Its predictive value for Alzheimer’s disease diagnosis Monge-Argilés, Antonio
2009
5 4S p. P345
artikel
1061 Metabolic syndrome and cognition in patients with manifest arterial disease: The SMART study Muller, Majon
2009
5 4S p. P378-P379
artikel
1062 Metabolism and BOLD measures of the resting state network: A comparative study in normal aging and mild cognitive impairment Mevel, Katell
2009
5 4S p. P200-P201
artikel
1063 Metabolism and BOLD measures of the resting state network: A comparative study in normal aging and Mild Cognitive Impairment Mevel, Katell
2009
5 4S p. P27-P28
artikel
1064 Metacognitive monitoring abilities and amyloid deposition imaging in normal elderly individuals Perrotin, Audrey
2009
5 4S p. P218-P219
artikel
1065 Metallothionein-IIA blocks copper mediated Aβ1-40 neurotoxicity Howells, Claire
2009
5 4S p. P417
artikel
1066 Methodological considerations when using proxy measures in dementia Marosszeky, Nick
2009
5 4S p. P240
artikel
1067 Methodological issues for preventive trials Gauthier, Serge
2009
5 4S p. P142-P143
artikel
1068 Methylation studies in brains from patients with familial Alzheimer's disease Graff, Caroline
2009
5 4S p. P146
artikel
1069 Methylation studies in brains from patients with familial Alzheimer's disease Brohede, Jesper
2009
5 4S p. P465
artikel
1070 Micelle-like structures during the early-stages of Aβ(1-40) and Aβ(1-42) Association Zagorski, Michael G.
2009
5 4S p. P116
artikel
1071 Microelectrode arrays and Alzheimer's disease: A novel in vitro investigative paradigm Varghese, Kucku
2009
5 4S p. P428
artikel
1072 Microencapsulated cells expressing VEGF reduce brain amyloid load and behavioral impairment in Alzheimer's disease Spuch, Carlos
2009
5 4S p. P417
artikel
1073 Microglia mediated and fractalkine receptor dependent neuron loss in a mouse model of Alzheimer's disease Fuhrmann, Martin
2009
5 4S p. P82
artikel
1074 MicroRNA dysregulation in frontotemporal lobar degeneration Rademakers, Rosa
2009
5 4S p. P166
artikel
1075 Microtubule stabilizing agents as tools to explore the mechanism of Tau neurotoxicity in Alzheimer's disease and other Tauopathies Barten, Donna M.
2009
5 4S p. P398
artikel
1076 Microtubules to form memory and Alzheimer's disease Mitsuyama, Fuyuki
2009
5 4S p. P396
artikel
1077 Microvascular pathology in Alzheimer's disease: Brain regional analyses of capillary networks Cullen, Karen M.
2009
5 4S p. P71
artikel
1078 Midlife respiratory function and risk of dementia Whitmer, Rachel A.
2009
5 4S p. P382
artikel
1079 Mild cognitive impairment and anxiety: Does the entity exist on a spectrum? Sinoff, Gary
2009
5 4S p. P81
artikel
1080 Mild cognitve impairment: A fluctuating cognitve state Britt III, William
2009
5 4S p. P449
artikel
1081 Mining ADNI for a predictive model of diagnostic conversions using Classification and Regression Trees (CART) Donohue, Michael
2009
5 4S p. P278-P279
artikel
1082 Misfolded tau protein in transgenic rat cortical neurons causes increased sensitivity to nitrosative stress Krajciova, Gabriela
2009
5 4S p. P315
artikel
1083 Misprocessing of Multiple Transmembrane Substrates Reveals Gamma-Secretase Dysfunction in Both Familial and Sporadic Alzheimer's Diseases Gandy, Samuel E.
2009
5 4S p. e3
artikel
1084 Mitochondrial aconitase of aged and Alzheimer brain as a target for endogenous anti- and pro-oxidants Karelson, Ello
2009
5 4S p. P473-P474
artikel
1085 Mitochondrial alpha-synuclein: Implications in neurodegenerative diseases Uéda, Kenji
2009
5 4S p. P488
artikel
1086 Modeling and simulation of plasma Aβ in humans after multiple oral doses of PF-3084014, a potent gamma-secretase inhibitor Qiu, Ruolun
2009
5 4S p. P253
artikel
1087 Modeling reserve with change over time Hemmy, Laura S.
2009
5 4S p. P388
artikel
1088 Moderate alcohol intake is associated with lower dementia incidence: results from the Ginkgo Evaluation of Memory Study (GEMS) Sink, Kaycee M.
2009
5 4S p. P105
artikel
1089 Moderate-to-severe cognitive impairment is common in patients with moderate chronic kidney disease Murray, Anne M.
2009
5 4S p. P394
artikel
1090 Modulation of APP trafficking by SH3 domains of Grb2 Raychaudhuri, Mithu
2009
5 4S p. P484-P485
artikel
1091 Modulation of catecholaminergic and cholinergic neurons in mice fed with LMN diet, rich in polyphenols and polyunsaturated fatty acids Bolea, Irene
2009
5 4S p. P330
artikel
1092 Modulation of endogenous TGF-β1 reduces microglial proliferation and Aβ deposition in a mouse model of Alzheimer's disease Ng, Vivian
2009
5 4S p. P488
artikel
1093 Modulation of synaptic function by extracellular tau enriched in oligomers Moe, James G.
2009
5 4S p. P499
artikel
1094 Modulation of synaptic transmission by Aβ peptides Moreno, Herman
2009
5 4S p. P497-P498
artikel
1095 Molecular analysis of GOLPH2 gene SNPs in Alzheimer's disease Antúnez, Carmen
2009
5 4S p. P460
artikel
1096 Molecular analysis of tau phosphorylation in a rat model of Alzheimer's disease revealed interplay between the endogenous rat tau and misfolded human Alzheimer's disease derived tau Kucerak, Juraj
2009
5 4S p. P402
artikel
1097 Molecular biomarkers for diagnosis and evaluation of treatment effects Zetterberg, Henrik
2009
5 4S p. P92
artikel
1098 Molecular imaging: Present and future prospects Rowe, Christopher C.
2009
5 4S p. P73
artikel
1099 Molecular insights into mechanism of alpha synuclein evoked inhibition of poly (ADP-ribose) polymerase-1 (PARP-1) activity Kaźmierczak, Anna
2009
5 4S p. P475
artikel
1100 Molecular neuropathology of frontotemporal lobar degeneration Neumann, Manuela
2009
5 4S p. P165-P166
artikel
1101 Molecular pathology of Alzheimer's disease Masliah, Eliezer
2009
5 4S p. P68
artikel
1102 Molecular signature of prodromal Alzheimer's disease: A microarray study in post-mortem cortical tissue Conejero-Goldberg, Concepcion
2009
5 4S p. P305
artikel
1103 Molecular simulations of beta-amyloid dimers in alzheimer's disease Chu, Yanching
2009
5 4S p. e21
artikel
1104 Monitoring drivers with dementia: An instrumented vehicle study Silverstein, Nina M.
2009
5 4S p. P140
artikel
1105 Morphological changes in the hippocampus predict MCI conversion to AD: An MR-based comparison between Moore-Rayleigh and permutation tests Ferrarini, Luca
2009
5 4S p. P368
artikel
1106 Morphological changes in the hippocampus predict MCI conversion to Alzheimer'S disease: An MR-based comparison between Moore-Rayleigh and permutation tests Ferrarini, Luca
2009
5 4S p. P25
artikel
1107 Most rapid cognitive decline in APOE4 negative Alzheimer's disease with early onset van der Flier, Wiesje M.
2009
5 4S p. P111-P112
artikel
1108 Motivational reserve and a resource-depletion account to Alzheimer's Maercker, Andreas
2009
5 4S p. P383
artikel
1109 Motivational reserve as risk factor in the development of mild cognitive impairment and Alzheimer's disease: Cross-sectional and longitudinal data Forstmeier, Simon
2009
5 4S p. P383
artikel
1110 Motor network rewiring in Mild Cognitive Impairment and Alzheimer's disease Agosta, Federica
2009
5 4S p. P29
artikel
1111 Motor network rewiring in mild cognitive impairment and Alzheimer's disease Agosta, Federica
2009
5 4S p. P370
artikel
1112 MRI validation of the NINDS-CSN proposed neuropsychological assessment protocol for vascular cognitive impairment Murphy, Christopher M.
2009
5 4S p. P196
artikel
1113 MRI validation of the NINDS-CSN proposed neuropsychological assessment protocol for vascular cognitive impairment Murphy, Christopher M.
2009
5 4S p. P19
artikel
1114 99mTc HMPAO SPECT prediction of conversion from mild cognitive impairment to Alzheimer's disease Devanand, D.P.
2009
5 4S p. P33-P34
artikel
1115 99mTc HMPAO SPECT prediction of conversion from mild cognitive impairment to Alzheimer's disease Devanand, D.P.
2009
5 4S p. P372
artikel
1116 MTHFR and ACE gene polymorphisms and risk of vascular and degenerative dementias in the elderly Pandey, Pratima
2009
5 4S p. P463
artikel
1117 Mucosal vaccination of elk-PrP transgenic mice to prevent prion transmission via an oral route Goni, Fernando
2009
5 4S p. e30-e31
artikel
1118 Multicenter quantitative amyloid PET imaging in Phase III Alzheimer's therapeutic trials: Strategies for achieving good imaging practices in the support of drug development P. Seibyl, John
2009
5 4S p. P265
artikel
1119 Multicenter quantitative amyloid PET imaging in phase III alzheimer therapeutic trials: Strategies for achieving good imaging practices in the support of drug development Seibyl, John P.
2009
5 4S p. P52
artikel
1120 Multidimensional biomarker-based diagnosis of early Alzheimer's disease Ewers, Michael
2009
5 4S p. P136-P137
artikel
1121 Multimodal approaches to studying risk of dementia and MCI - investigating a birth cohort Fischer, Peter
2009
5 4S p. P96
artikel
1122 MultiModal imaging and connectivity: What leads to what and where in Alzheimer's disease Buckner, Randy L.
2009
5 4S p. P73
artikel
1123 Multivariate Data Analysis Of Regional MRI Volumes and Cortical Thickness Measures To Distinguish Between Alzheimer's Disease, Mild Cognitive Impairment And Healthy Controls Simmons, Andrew
2009
5 4S p. e16
artikel
1124 Muscarinic M1 receptor in the neocortex of vascular and mixed dementia patients: Selective reduction in subcortical ischemic disease Lee, Jasinda
2009
5 4S p. P491
artikel
1125 Muscarinic receptor 1 agonist activity of novel arecoline derivatives in Alzheimer's dementia models Rangappa, K.S.
2009
5 4S p. P243
artikel
1126 Music therapist robot for people suffering from dementia: Longitudinal study Tapus, Adriana
2009
5 4S p. P338
artikel
1127 Needs of caregivers’ patients with dementia Rosa, Erika
2009
5 4S p. P232
artikel
1128 Neural correlates of focused attention in cognitively normal older adults and patients with Alzheimer's disease Bowes, Jennifer R.
2009
5 4S p. P64
artikel
1129 Neural correlates of focused attention in cognitively normal older adults and patients with Alzheimer's disease R. Bowes, Jennifer
2009
5 4S p. P271
artikel
1130 Neural correlates of object memory in amnestic mild cognitive impairment and Alzheimer's disease He, Yi
2009
5 4S p. P358-P359
artikel
1131 Neural correlates of semantic processing in older adults with cognitive complaints and amnestic MCI Taler, Vanessa
2009
5 4S p. P269
artikel
1132 Neural correlates of semantic processing in older adults with cognitive complaints and amnestic MCI Taler, Vanessa
2009
5 4S p. P62
artikel
1133 Neural underpinnings of autobiographical memory retrieval in Alzheimer's disease Meulenbroek, Olga
2009
5 4S p. P3
artikel
1134 Neuroengineering in Alzheimer's disease research: Using a virtual brain laboratory Koene, Randal A.
2009
5 4S p. P321-P322
artikel
1135 Neuroimaging analysis of human apolipoprotein E targeted replacement mice that overexpress amyloid precursor protein Dellovade, Tammy
2009
5 4S p. P436
artikel
1136 Neuroimaging in living APP transgenic mice reveals unexpected findings Luo, Feng
2009
5 4S p. P83
artikel
1137 Neuroimaging with synchrotron radiation-based techniques in Parkinson's disease Szczerbowska-Boruchowska, Magdalena
2009
5 4S p. P215
artikel
1138 Neuronal and microglial RAGE-dependent signal pathways involved in Aβ-induced synaptic dysfunction in entorhinal cortex Origlia, Nicola
2009
5 4S p. P498
artikel
1139 Neuronal destruction by Aβ oligomers is linked to NMDA-receptor signaling Reymann, Klaus G.
2009
5 4S p. P497
artikel
1140 Neuronal Function of the Amyloid Precursor Protein of Alzheimer's Disease Octave, Jean-Noel
2009
5 4S p. e2
artikel
1141 Neuronal hypertrophy in asymptomatic Alzheimer's disease Troncoso, Juan C.
2009
5 4S p. P70
artikel
1142 Neuronal IGF-1 resistance protects against premature death and reduces β-Amyloid accumulation in Tg2576 mice Hettich, Morritz M.
2009
5 4S p. P84
artikel
1143 Neuronal receptors mediating toxicity of Abeta oligomers Strittmatter, Stephen M.
2009
5 4S p. P121
artikel
1144 Neuropathological characterization of progranulin-deficient mice: Accelerated lipofuscin accumulation suggests a role for progranulin in successful aging Lewis, Jada M.
2009
5 4S p. P161-P162
artikel
1145 Neurophysiology of human memory: the effects of Alzheimer's disease risk factors McLaren, Donald G.
2009
5 4S p. P213
artikel
1146 Neuroprotection effect of genoside and giniposide against Abeta1-42 Li, Xiaojing
2009
5 4S p. P64
artikel
1147 Neuroprotection effect of genoside and giniposide against abeta1-42 Li, Xiaojing
2009
5 4S p. P413
artikel
1148 Neuroprotective effects of cerebrolysin on neurofibrillary pathology in APP-transgenic mice that received neuronal gene transfer with AAV2-TAU Jech, Marion
2009
5 4S p. P434-P435
artikel
1149 Neuropsychiatric inventory for alzheimer's disease and mild cognitive impairment's patients with new classification methods Kim, Taewan
2009
5 4S p. P228-P229
artikel
1150 Neuropsychiatric predictors of progression from Mild Cognitive Impairment to Alzheimer's Disease Palmer, Katie
2009
5 4S p. P130
artikel
1151 Neuropsychiatric symptoms in mild cognitive impairment Choi, Mun Seong
2009
5 4S p. P360
artikel
1152 Neuropsychological correlates and brain substrates of anosognosia in mild cognitive impairment Chetelat, Gaël
2009
5 4S p. P80-P81
artikel
1153 Neuropsychological domains in mild cognitive impairment and normal aging: Results from the NACC UDS study Hayden, Kathleen M.
2009
5 4S p. P448
artikel
1154 Neuropsychological performance and the e4 and e2 alleles: Findings from the first phase of the australian imaging, biomarker and lifestyle (AIBL) flagship study of ageing Foster, Jonathan K.
2009
5 4S p. P160-P161
artikel
1155 Neuropsychology and cerebral perfusion (HMPAO-SPECT) in patients with subjective cognitive complaints and mild cognitive impairment Staffen, Wolfgang
2009
5 4S p. P200
artikel
1156 Neuropsychology and cerebral perfusion (HMPAO-SPECT) in patients with ‘subjective cognitive complaints’ and ‘Mild Cognitive Impairment’ Staffen, Wolfgang
2009
5 4S p. P26
artikel
1157 Neurostructural Predictors Of Conversion To Alzheimer'S Disease: A Meta-analysis Of Vbm Studies Ferreira, Luiz K.
2009
5 4S p. e10
artikel
1158 NeuroVitalis®: Effects of a new neuropsychological training in healthy elderly individuals and early-stage Alzheimer patients Kaesberg, Stephanie
2009
5 4S p. P332
artikel
1159 New aspects of membrane breakdown in Alzheimer's disease brain Elisabeth, Kienzl
2009
5 4S p. P474
artikel
1160 New metabolic understanding into innovative strategies for early diagnostics and therapy of Alzheimer's disease Fedoriv, Ivan V.
2009
5 4S p. P15
artikel
1161 New metabolic understanding into innovative strategies for early diagnostics and therapy of Alzheimer's disease Fedoriv, Ivan V.
2009
5 4S p. P272
artikel
1162 New research insights pleading for old procaine as a new hope in treatment of comorbid depression Ileana, Turcu
2009
5 4S p. P340
artikel
1163 Nic5-15: a novel natural gamma-secretase inhibitor that attenuates brain beta-amyloid content and improves cognition Pasinetti, Giulio
2009
5 4S p. e28
artikel
1164 NIC5-15 as a treatment for Alzheimer's: Safety, pharmacokinetics and clinical variables Grossman, Hillel
2009
5 4S p. P259
artikel
1165 NMDA receptors and postsynaptic protein PSD-95 changes are associated in Alzheimer entorhinal and frontal cortex Leuba, Geneviève
2009
5 4S p. P298
artikel
1166 Noninvasive Detection Of α-synuclein Deposits In Human Brain Using [11C]BF227-PET Okamura, Nobuyuki
2009
5 4S p. e4
artikel
1167 Nonlinear registration of serial MR imaging of hippocampus and whole brain: increased atrophy rates and memory complaints Sokolska, Madalena J.
2009
5 4S p. P28
artikel
1168 Norepinephrine deficiency aggravates learning and memory impairment independent of amyloid-beta levels in APP PS1 mice Hammerschmidt, Thea
2009
5 4S p. P499
artikel
1169 Norepinephrine modulates salutary microglial functions in transgenic models of Alzheimer's disease Heneka, Michael T.
2009
5 4S p. P153
artikel
1170 Novel age-dependent learning deficits in a mouse model of Alzheimer's disease: Implications for translational research Montgomery, Karienn S.
2009
5 4S p. P442
artikel
1171 Novel APLP1 Peptide In CSF Is Useful For Diagnosis Of Sporadic Alzheimer's Disease Okochi, Masayasu
2009
5 4S p. e16-e17
artikel
1172 Novel APP mutation p.E682K at the β’ processing site is associated with early-onset Alzheimer's disease Brouwers, Nathalie
2009
5 4S p. P148-P149
artikel
1173 Novel biomarkers for the differential diagnosis of Alzheimer's disease and vascular dementia Simonsen, Anja H.
2009
5 4S p. P344
artikel
1174 Novel downstream mediators of APP signalling Bredesen, Dale E.
2009
5 4S p. P88-P89
artikel
1175 Novel mechanism where ApoE mimetics activate PP2A activity and reduce Alzheimer's pathology in three different transgenic models Vitek, Michael P.
2009
5 4S p. P111
artikel
1176 Novel TARDBP mutation associated with frontotemporal dementia and movement disorder but not motor neuron disease Kovacs, Gabor G.
2009
5 4S p. P501
artikel
1177 Nsaids modulate app dimerization Richter, Luise
2009
5 4S p. P402
artikel
1178 Obsessive-compulsive symptoms in Alzheimer's disease and frontotemporal dementia Rascovsky, Katya
2009
5 4S p. P504
artikel
1179 Occupational exposure to pesticides increases the risk of Alzheimer's disease: Findings from the Cache County Study Hayden, Kathleen M.
2009
5 4S p. P128-P129
artikel
1180 O-GlcNAc regulation of hippocampal synaptic plasticity in wild type and 3xTg-AD mice Vosseller, Keith
2009
5 4S p. P497
artikel
1181 Olfactory receptor cluster copy number is associated with age at onset of Alzheimer's disease Szigeti, Kinga
2009
5 4S p. P469
artikel
1182 Oligomeric Aβ40 species accumulate in the toxic plaques in Alzheimer's disease Shepherd, Claire E.
2009
5 4S p. P107
artikel
1183 Omega-3 fatty acid deficit in Alzheimer's disease Astarita, Giuseppe
2009
5 4S p. P343
artikel
1184 Omega-3 Polyunsaturated Fatty Acids, Apoe ε4 Allele Status, And Cognitive Functioning In Community-dwelling Older Adults Danthiir, Vanessa
2009
5 4S p. e21
artikel
1185 Once-daily memantine treatment improves cognition and functional communication in patients with moderate to severe AD: Results of a 16-week, single-arm, open-label trial Schulz, Joerg
2009
5 4S p. P252
artikel
1186 One-carbon metabolism and DNA methylation: Molecular mechanisms and possible intervention in Alzheimer's disease Fuso, Andrea
2009
5 4S p. P147
artikel
1187 Open-label Treatment Of Combined Memantine Plus Escitalopram Treatment In Elderly Depressed Patients With Cognitive Impairment Pelton, Gregory H.
2009
5 4S p. e17
artikel
1188 Opposite effects of cerebrolysin on serum TNF-alpha and IGF-I levels in Alzheimer's disease Alvarez, Anton
2009
5 4S p. P257
artikel
1189 Opposite role of SIRT1 and SIRT2 in neurodegeneration Polito, Letizia
2009
5 4S p. P314
artikel
1190 Optimizing fmri test-retest reliability and power estimates for alzheimer's disease early-phase studies: Modeling decline and leveraging network properties Atri, Alireza
2009
5 4S p. P37
artikel
1191 Optimizing FMRI test-retest reliability and power estimates for Alzheimer's disease early-phase studies: Modeling decline and leveraging network properties Atri, Alireza
2009
5 4S p. P373
artikel
1192 Optimizing the therapeutic targeting of alpha7 nAChR for the treatment of Alzheimer's disease Papke, Roger L.
2009
5 4S p. P335
artikel
1193 Oral amyloid anti-aggregating agent ELND005 is measurable in CSF and brain of healthy adult men Garzone, Pamela
2009
5 4S p. P323
artikel
1194 Oral treatment with an Aβ42 oligomer modulating D-amino acid peptide improves cognitive behavior of APP/ PS1 double transgenic mice Willbold, Dieter
2009
5 4S p. P137
artikel
1195 Organelle-targeted Ca2+ probes help to visualize store Ca2+ handling by wild-type and mutant presenilin-2 Zampese, Enrico
2009
5 4S p. P318
artikel
1196 Overcoming recruitment challenges for brain tissue donation: The University of Wisconsin, Madison Alzheimer's Disease Brain Bank Erwin, Kara M.
2009
5 4S p. P278
artikel
1197 Overexpression Of Apolipoprotein E4 Exacerbates Kainic Acid-induced Hippocampal Neurodegeneration Adem, Abdu
2009
5 4S p. e7
artikel
1198 Overexpression of inflammation markers in Alzheimer's disease: Clinical correlates Alvarez, Anton
2009
5 4S p. P133
artikel
1199 Overexpression of inhibitor 1 of protein phosphatase 2A in the hippocampus of transgenic mice: Effects on behavior and pathology Hirko, Aaron C.
2009
5 4S p. P403-P404
artikel
1200 Overexpression of inhibitor-1 or -2 of protein phosphatase-2A causes abnormal hyperphosphorylation of tau and cognitive impairment in the rat Iqbal, Khalid
2009
5 4S p. P135
artikel
1201 Overexpression of mutant tau in mice leads to tau aggregation and deterioration of motor skills Zabke, Claudia
2009
5 4S p. P442-P443
artikel
1202 Overexpression of Wild-type TDP-43 Leads to Motor Neuron Degeneration and Spastic Quadriplegia in Germline Transgenic Mice Kumar-Singh, Samir
2009
5 4S p. e4
artikel
1203 Over-induced apoptosis expression of tau protects cells from ER stress Liu, Xinan
2009
5 4S p. P309
artikel
1204 Oxidative lipid modification of nicastrin enhances Aβ production in Alzheimer's disease Jo, Dong-Gyu
2009
5 4S p. P314
artikel
1205 Oxidative stress in hippocampal primary neurons: Iron entry and iron-mediated toxicity Pelizzoni, Ilaria
2009
5 4S p. P314
artikel
1206 Oxidative stress in patients with MCI increases the risk of developing Alzheimer's disease Padurariu, Manuela
2009
5 4S p. P505
artikel
1207 Pain interference is associated with an increased risk of dementia: Results from the Einstein Aging Study (EAS) Lipton, Richard B.
2009
5 4S p. P295
artikel
1208 p3-Alc peptides produced by covariant processing of Alcadein and APP implicate γ-secretase dysfunction in sporadic Alzheimer's disease Hata, Saori
2009
5 4S p. P316-P317
artikel
1209 Paradigm shift from Alzheimer-centric view of brain aging and dementia: Dynamic Polygon Hypothesis Fotuhi, Majid
2009
5 4S p. P275-P276
artikel
1210 Parkinsonism variant of alzheimer disease with DLB: Presenting PSP-like clinical and radiological findings Kasahata, Naoki
2009
5 4S p. P183-P184
artikel
1211 Passive immunization with natural occurring anti-abeta antibodies leads to differential effects on cognition in APP transgenic mice Roeskam, Stephan
2009
5 4S p. P432
artikel
1212 Pathology of the hippocampal formation in patients with multiple system atrophy with and without dementia Kovács, Tibor
2009
5 4S p. P503
artikel
1213 Pattern of brain atrophy in MCI with hippocampal amnestic syndrome is similar to Alzheimer’s disease Bombois, Stéphanie
2009
5 4S p. P369-P370
artikel
1214 Patterns of brain atrophy in frontotemporal dementia with mutations in MAPT or PGRN Whitwell, Jennifer L.
2009
5 4S p. P4
artikel
1215 Patterns of brain atrophy in frontotemporal dementia with mutations in MAPT or PGRN Whitwell, Jennifer L.
2009
5 4S p. P405
artikel
1216 Patterns of correlation between Aβ deposition and glucose metabolism across the spectrum of mild cognitive impairment to Alzheimer's disease Cohen, Ann D.
2009
5 4S p. P76
artikel
1217 PBT2 for Alzheimer's disease: An update on clinical development Ritchie, Craig W.
2009
5 4S p. P74
artikel
1218 Pbt2 for Pre-dementia Alzheimer's Disease: Animal and Clinical Evidence Bush, Ashley I.
2009
5 4S p. e5
artikel
1219 PDE9A-mediated regulation of cGMP: Developing a biomarker for a novel therapy for Alzheimer's disease Schmidt, Christopher J.
2009
5 4S p. P331
artikel
1220 Perception of stigma and willingness to participate in a cohort study among proxy respondents and controls in Shanghai, China: Scobhi-pilot Copenhaver, Cathleen
2009
5 4S p. P410
artikel
1221 Peripheral administration of lipopolysaccharide induces a deficit in a rodent spatial learning and memory task Wong, Fong Kuan K.
2009
5 4S p. P179
artikel
1222 Perlecan Domain V Inhibits Brain Endothelial Cell Abeta Toxicity in Vitro Bix, Gregory J.
2009
5 4S p. e24
artikel
1223 Per-protocol analysis versus ITT in Alzheimer's preventive trials Sampaio, Cristina
2009
5 4S p. P143
artikel
1224 PET Amyloid imaging and cognition in patients with Alzheimer's disease, Mild Cognitive Impairment (MCI) and healthy controls: a European multicenter study Nordberg, Agneta
2009
5 4S p. P2
artikel
1225 PET imaging for mild cognitive impairment with FDG and beta-amyloid tracer, 11C-BF-227 Furukawa, Katsutoshi
2009
5 4S p. P22-P23
artikel
1226 PET imaging for mild cognitive impairment with FDG and beta-amyloid tracer, 11C-BF-227 Furukawa, Katsutoshi
2009
5 4S p. P366
artikel
1227 PET imaging of β-amyloid with florpiramine F18 (18F-AV-45): Preliminary results from a phase II study of cognitively normal elderly subjects, individuals with mild cognitive impairment, and patients with a clinical diagnosis of Alzheimer's disease Sperling, Reisa
2009
5 4S p. P197
artikel
1228 Pet imaging of translocator protein (TSPO) in elderly controls using [11C]DPA-713 Rosenberg, Paul B.
2009
5 4S p. P482
artikel
1229 PF-04447943, a novel PDE9A inhibitor, increases cGMP levels in cerebrospinal fluid: Translation from non-clinical species to healthy human volunteers Nicholas, Timothy
2009
5 4S p. P330-P331
artikel
1230 PGC-1-α is a protective factor for Alzheimer's disease Sastre, Magdalena
2009
5 4S p. P494
artikel
1231 Phagocytosis Is Associated With Increased Secretion Of N-terminally Truncated beta-amyloid Peptides In Human Mononuclear Phagocytes Spitzer, Philipp
2009
5 4S p. e15
artikel
1232 Pharmacokinetic and pharmacodynamic analysis of a novel gamma secretase inhibitor in a non-transgenic A-beta mouse efficacy model Quinn, Kevin P.
2009
5 4S p. P182
artikel
1233 Pharmacokinetic and pharmacodynamic analysis of a novel gamma secretase inhibitor in a nontransgenic A-beta mouse efficacy model Quinn, Kevin P.
2009
5 4S p. P437
artikel
1234 Pharmacokinetic and pharmacodynamic evaluation of PF-04360365, a humanized monoclonal anti-amyloid antibody, in young and aged cynomolgus monkeys Wang, Ellen Q.
2009
5 4S p. P423
artikel
1235 Pharmacokinetics and pharmacodynamics of bapineuzumab following multiple intravenous infusions in patients with mild-to-moderate Alzheimer's disease Raskind, Murray
2009
5 4S p. P415-P416
artikel
1236 Pharmacological and behavioral profile of EVP-5141, a novel α7 nicotinic acetylcholine receptor agonist Boess, Frank
2009
5 4S p. P245
artikel
1237 Pharmacological manipulation of Hsp90 and its effects on phospho-tau species in an AD-relevant cell-based model Glover, Sarah J.
2009
5 4S p. P397
artikel
1238 Pharmacological modulation of human photosynthesis: A new approach to Alzheimer's disease Solis-Herrera, Arturo
2009
5 4S p. P319
artikel
1239 Pharmacological Validation Of The Canine Model Of Alzheimer's Disease: Donepezil Improves Memory In Cognitively Impaired Aged Beagle Dogs Araujo, Joseph A.
2009
5 4S p. e23
artikel
1240 Pharmacologic and pharmacokinetic equivalence studies of GE-067 to PiB A. Mathis, Chester
2009
5 4S p. P262
artikel
1241 Phase II study of the 18F labelled PiB derivative GE067 Vandenberghe, Rik
2009
5 4S p. P77
artikel
1242 Phenotypes and genotypes in presenilin 2 (PSEN2) mutations Jayadev, Suman
2009
5 4S p. P464
artikel
1243 Phenotypic and genetic subclassification of Alzheimer's disease Thal, Dietmar R.
2009
5 4S p. P107
artikel
1244 Phosphorylated TDP-43 in neurodegenerative disorders Arai, Tetsuaki
2009
5 4S p. P501-P502
artikel
1245 Phosphorylation-dependent association of tau with the neuronal membrane Pooler, Amy M.
2009
5 4S p. P404
artikel
1246 Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis Vassar, Robert
2009
5 4S p. P81-P82
artikel
1247 Physical activity and prevention of cognitive decline Lautenschlager, Nicola T.
2009
5 4S p. P144
artikel
1248 Physical activity as a protective factor in a prospective ageing study in Germany Sattler, Christine
2009
5 4S p. P292
artikel
1249 PiB negative dementia: Pitfall of clinical diagnosis of AD Shimada, Hiroyuki
2009
5 4S p. P194-P195
artikel
1250 PiB negative dementia: Pitfall of clinical diagnosis of Alzheimer's disease Shimada, Hiroyuki
2009
5 4S p. P17
artikel
1251 PiB PET Classification: A model to determine those who are at risk of developing AD Fripp, Jurgen
2009
5 4S p. P195-P196
artikel
1252 PiB PET Classification: A model to determine those who are at risk of developing Alzheimer's disease Fripp, Jurgen
2009
5 4S p. P18
artikel
1253 PICOGEN: A genetic counseling program experience in dementia Fortea, Juan
2009
5 4S p. P463
artikel
1254 Place of neuropsychological assessment versus biomarkers in the assessment of Alzheimer's disease Salmon, Eric
2009
5 4S p. P142
artikel
1255 Plaque-associated dystrophic neurite pathology in three transgenic mice lines carrying human APP FAD mutations are indicative of structural injury to axons and identical to preclinical Alzheimer's disease Vickers, James C.
2009
5 4S p. P443
artikel
1256 Plasma Aß42/Aß40 ratio is decreased in amnestic Mild Cognitive Impairment (MCI) and mild Alzheimer's Disease (AD) Buerger, Katharina
2009
5 4S p. P348
artikel
1257 Plasma ceramides predict hippocampal atrophy and progression in memory impairment among amnestic Mild Cognitive Impairment participants Mielke, Michelle M.
2009
5 4S p. P351-P352
artikel
1258 Plasma F2-isoprostane level does not predict cognitive function in non-demented elderly: Findings from the health abc study Fiocco, Alexandra J.
2009
5 4S p. P391
artikel
1259 Plasma Noradrenaline Level In Alzheimer's Disease And Mild Cognitive Impairment (MCI) Oka, Mizuki
2009
5 4S p. e13
artikel
1260 Polymorphism of glutathione-s-transferase (GSTM1 and T1) in dementia of Alzheimer's type in North Indian population: A preliminary study Ghosh, Tandra
2009
5 4S p. P290
artikel
1261 Polyunsaturated fatty acids are inversely associated with MCI: The Mayo Clinic Study of Aging Roberts, Rosebud O.
2009
5 4S p. P295-P296
artikel
1262 Population-based survey in Greece: Cognitive performance vs demographic, medical history and memory complaints Sakka, Paraskevi
2009
5 4S p. P381-P382
artikel
1263 Posiphen lowers amyloid precursor protein and amyloid β as well as acetylcholinesterase levels in culture, animals and humans Maccecchini, Maria L.
2009
5 4S p. P247-P248
artikel
1264 Positive effects of a 6-month stage-specific cognitive intervention program on brain metabolism in subjects with amnestic mild cognitive impairment (aMCI) and mild Alzheimer's disease (AD) Foerster, Stefan
2009
5 4S p. P38
artikel
1265 Positive effects of a 6-month stage-specific cognitive intervention program on brain metabolism in subjects with amnestic mild cognitive impairment (aMCI) and mild Alzheimer's Disease (AD) Foerster, Stefan
2009
5 4S p. P205-P206
artikel
1266 Possible mutual interaction between diabetes mellitus and Alzheimer's disease: Generation of novel transgenic mice models of Alzheimer's disease with diabetic conditions Takeda, Shuko
2009
5 4S p. P154-P155
artikel
1267 Post-traumatic stress disorder and risk of dementia among U.S. veterans Yaffe, Kristine
2009
5 4S p. P104
artikel
1268 Potential gene expression biomarkers in whole blood of Alzheimer's disease Grünblatt, Edna
2009
5 4S p. P148
artikel
1269 Potential gene expression biomarkers in whole blood of Alzheimer's disease Cacabelos, Ramon
2009
5 4S p. P148
artikel
1270 Potential role of the formyl-peptide-receptors and scavenger receptor MARCO in the signal transduction of amyloid beta 1-42 (Aβ42) in glial cells Brandenburg, Lars-Ove
2009
5 4S p. P490
artikel
1271 PP1 Inhibition By Aβ Peptide And Aluminum As A Potential Pathological Mechanism In Alzheimer's Disease da Cruz e Silva, Edgar F.
2009
5 4S p. e16
artikel
1272 p25 protein is a modulator of gamma-cleavage through the mechanism common to TMP21 Hasegawa, Hiroshi
2009
5 4S p. P316
artikel
1273 Preclinical Alzheimer's disease cannot be reliably identified in the antemortem setting using standard clinical and neuropsychological test measures Jicha, Gregory A.
2009
5 4S p. P459
artikel
1274 Predicting Alzheimer's Disease Petersen, Ronald C.
2009
5 4S p. P130
artikel
1275 Predicting cognitive impairments based on clinical data Trtica-Majnaric, Ljiljana
2009
5 4S p. P394
artikel
1276 Predicting costs of care for unique dependence levels in patients with Alzheimer's disease Murman, Daniel L.
2009
5 4S p. P408
artikel
1277 Predicting the risk for Alzheimer's disease using functional MRI van der Meulen, Marian
2009
5 4S p. P11
artikel
1278 Prediction of Alzheimer dementia with short neuropsychological instruments Jungwirth, Susanne
2009
5 4S p. P159-P160
artikel
1279 Prediction of Alzheimer's disease by means of a biomarker profile in the Rotterdam Study Schrijvers, Elisabeth M.C.
2009
5 4S p. P132
artikel
1280 Prediction of cognitive decline in normal older persons without subjective cognitive impairment: A seven year longitudinal study Reisberg, Barry
2009
5 4S p. P272
artikel
1281 Prediction of neuropathology in primary progressive language and speech disorders Deramecourt, Vincent
2009
5 4S p. P79
artikel
1282 Prediction of treatment response to rivastigmine in Parkinson's Disease Dementia Adler, Georg
2009
5 4S p. P252
artikel
1283 Predictive Analyses of Institutionalisation in Dementia and Mild Cognitive Impairment Patients Woodward, Michael
2009
5 4S p. P275
artikel
1284 Predictors of cognitive dysfunction among community dwelling elderly in southern Brazil Godinho, Claudia
2009
5 4S p. P284
artikel
1285 Predictors of improvement in cognitive ability in Chinese persons with mild cognitive impairment: A 2-year follow up Lam, Linda C.
2009
5 4S p. P365
artikel
1286 Predictors of successful cognitive aging: Findings from the cache county memory study Welsh-Bohmer, Kathleen A.
2009
5 4S p. P295
artikel
1287 Predictors of the decline in behavioral and psychological symptoms over one year during the course of Alzheimer's disease Mok, Wing Yee Winnie
2009
5 4S p. P448
artikel
1288 Preferential uptake of Aβ1-42 oligomers over fibrils by primary human astrocytes in vitro Nielsen, Henrietta M.
2009
5 4S p. P173
artikel
1289 p73 regulates neurodegeneration, stem cell self-renewal, and phospho-Tau accumulation during aging and Alzheimer's disease Kaplan, David R.
2009
5 4S p. P70-P71
artikel
1290 Preliminary population pharmacokinetic modeling of PF-04360365, a humanized anti-amyloid monoclonal antibody, in patients with mild-to-moderate Alzheimer's disease Nicholas, Timothy
2009
5 4S p. P253
artikel
1291 Presenilin-1 (PS1) and amyloid precursor protein (APP) mutations present in mouse models of Alzheimer's disease in their response to γ-secretase inhibitors and modulators Lehmann, Stefanie
2009
5 4S p. P422-P423
artikel
1292 Presenilin-1 Val97Leu mutation induces hyperphosphorylation of tau through activating glycogen synthase kinase-3 Wang, Yue
2009
5 4S p. P395
artikel
1293 Preservation of cognitive functioning in depressed, demented geriatric patients with cardiovascular risk factors: An ongoing 3-year naturalistic study Bragin, Valentin
2009
5 4S p. P320
artikel
1294 Preservation of learning abilities in people with dementia and depression with different level of cognitive impairment Bragin, Valentin
2009
5 4S p. P322
artikel
1295 Prevalence and illnesses causing early-onset dementia in Japan: A multi-center study Ikejima, Chiaki
2009
5 4S p. P288
artikel
1296 Prevalence and profile of focal cortical non-AD dementias in a South Indian memory clinic Alladi, Suvarna
2009
5 4S p. P187-P188
artikel
1297 Prevalence of behavioral symptoms and associated caregiver burden in a group of Mexican patients with dementia Perez Zepeda, Mario U.
2009
5 4S p. P183
artikel
1298 Prevalence of beta-amyloid plaques in a nondemented population using [11C]PIB and PET: Impact of APOE genotype Mintun, Mark A.
2009
5 4S p. P5
artikel
1299 Prevalence of cognitive impairment and dementia in a cohort of oldest old in Brazil: The Pietà study Caramelli, Paulo
2009
5 4S p. P391-P392
artikel
1300 Prevalence of dementia in the older elderly population in Japan: The Kurihara Project and the Osaki-Tajiri Project Meguro, Kenichi
2009
5 4S p. P384
artikel
1301 Prevalence of major psychiatric disorders in a cohort of oldest old in Brazil: The Pietà study Teixeira, Antonio L.
2009
5 4S p. P392
artikel
1302 Prevalence of MCI in a community-based population Trittschuh, Emily H.
2009
5 4S p. P357
artikel
1303 Prevalence of neuropsychiatric symptoms among older adults in the united states: The aging, demographics, and memory study Okura, Toru
2009
5 4S p. P374
artikel
1304 Prevalence of sleep disorders in an MCI population and association with cognitive subtypes Bombois, Stéphanie
2009
5 4S p. P385
artikel
1305 Prevalence study in Shanghai Ding, Ding
2009
5 4S p. P120
artikel
1306 Prevalence study in Shanghai Ding, Ding
2009
5 4S p. P122
artikel
1307 Preventing C31 generation does not prevent many Aβ-dependenent neuronal and behavioral impairments in the happ-J20 mouse model of Alzheimer's disease Devidze† , Nino
2009
5 4S p. P259
artikel
1308 Preventing cognitive decline in elderly demented/depressed patients and in ApoE4 mouse as a model of human Alzheimer's disease by feeding acetyl-l-carnitine and lipoic acid Aliev, Gjumrakch
2009
5 4S p. P152
artikel
1309 Prevention And Treatment Of Cognitive Decline In Elderly Demented/depressed Patients Using Apoe4 Tg+ Mice As A Model Of Human AD By Feeding Acetyl-L-carnitine And R-α-Lipoic Acid Aliev, Gjumrakch
2009
5 4S p. e25
artikel
1310 Prevention of dementia by intensive vascular care: PreDIVA Richard, Edo
2009
5 4S p. P158
artikel
1311 Primary neuropathologic diagnosis and co-occurrence of other neuropathologic features: Results from the National Alzheimer's Coordinating Center (NACC) Kukull, Walter A.
2009
5 4S p. P71-P72
artikel
1312 Prion-induced neurodegeneration in organotypic brain slice cultures Falsig, Jeppe
2009
5 4S p. P167
artikel
1313 Procedural skill learning in Alzheimer's disease: Goal vs. action Press, Daniel
2009
5 4S p. P453
artikel
1314 Processing of the amyloid precursor protein: Role of protein kinase C and myosin IIB Argellati, Francesca
2009
5 4S p. P493
artikel
1315 Prodromal Alzheimer's disease: Data from the PAQUID study Dartigues, Jean François
2009
5 4S p. P145
artikel
1316 Profiles of apathy: Different features among patients with frontotemporal lobar degeneration and Alzheimer's disease Ketelle, Robin
2009
5 4S p. P233
artikel
1317 Profiling Of Membrane-anchored β-secretase Inhibitors In Cell Cultures Schieb, Heinke
2009
5 4S p. e13
artikel
1318 Progranulin correlates with dense-core plaque burden in Alzheimer's disease mouse models Pereson, Sandra
2009
5 4S p. P83
artikel
1319 Progranulin gene polymorphism (GRN rs5848) that is associated with FTLD-U is increased in African-Americans and shows a tendency to correlate with cognitive performance in subjects enrolled in the Einstein Aging Study Derby, Carol A.
2009
5 4S p. P470-P471
artikel
1320 Progranulin (GRN), a protein mutated in frontotemporal dementia with ubiquitin-positive inclusions (FTLD-U), is abundantly expressed in human gliomas Ness, Julia S.
2009
5 4S p. P502
artikel
1321 Progranulin Leu271LeufsX10 is one of the most common frontotemporal lobar degeneration and corticobasal syndrome associated mutations worldwide Benussi, Luisa
2009
5 4S p. P406
artikel
1322 Prominent attention deficits after superior cerebellar artery territory cerebellar infarct Cho, Soo-Jin
2009
5 4S p. P194
artikel
1323 Promising nonpharmacologic interventions to manage behavioral symptoms: Outcomes and Methodological challenges Gitlin, Laura
2009
5 4S p. P98
artikel
1324 Propagation of Lewy pathology through cell-to-cell transmission of alpha-synuclein Lee, Seung-Jae
2009
5 4S p. P124
artikel
1325 Prospective study of diabetes and cognitive decline and dementia subtypes in Cache County, Utah, USA Munger, Ronald G.
2009
5 4S p. P389
artikel
1326 Proteasome inhibition increases Aβ load and the underlying mechanisms in rat brain Liu, Yinghua
2009
5 4S p. P43
artikel
1327 Proteasome inhibition increases Aβ load and the underlying mechanisms in rat brain Liu, Yinghua
2009
5 4S p. P221-P222
artikel
1328 Protective effect of endogenous PS1 holoprotein under ER stress condition Sanjo, Nobuo
2009
5 4S p. P227
artikel
1329 Protective effect of mangosteen extract against β-amyloid-induced apoptosis in SK-N-SH cells Neungton, Neelobol
2009
5 4S p. P413-P414
artikel
1330 Protective effect of parathyroid hormone on hippocampal neurons in amyloid-beta 1-42 peptide-induced model of Alzheimer's disease in rats Mnatsakanyan, Vazgen R.
2009
5 4S p. P328
artikel
1331 14-3-3 protein differentially interacts with 3-repeat and 4-repeat tau Tanaka, Toshihisa
2009
5 4S p. P400
artikel
1332 Protein phosphatase 2A: A novel pharmaceutical target for the treatment of Alzheimer's disease Stock, Jeffry B.
2009
5 4S p. P319
artikel
1333 Protein phosphatase 2A facilitates axonogenesis: A promising molecule in preserving axons Zheng, Hongyun
2009
5 4S p. P473
artikel
1334 Protein phosphatase-2a inhibitor-2 up-regulates p53 and akt-implication for a new mechanism for alzheimer neurodegeneration Gongping, Liu
2009
5 4S p. P43
artikel
1335 Protein phosphatase-2A inhibitor-2 up-regulates p53 and Akt-implication for a new mechanism for Alzheimer's neurodegeneration Gongping, Liu
2009
5 4S p. P310-P311
artikel
1336 Proteolytic processing of membrane anchored Neuregulin1 in cell culture Tatsumi, Shin-ichi
2009
5 4S p. P228
artikel
1337 Proteome-based identification of plasma biomarkers predicting in vivo brain amyloid burden during normal aging Thambisetty, Madhav
2009
5 4S p. P132-P133
artikel
1338 Proton spectroscopy and neuropsychiatric syndromes in Alzheimer's disease and cognitive impairment non-dementia: A community-based study Santos Tascone, Lyssandra
2009
5 4S p. P269-P270
artikel
1339 Psychological profile and previous personality traits in Alzheimer's disease Reich, Edgardo G.
2009
5 4S p. P340
artikel
1340 Psychological resilience and the well-being of spousal caregivers of persons with alzheimer disease Naslund, John
2009
5 4S p. P230-P231
artikel
1341 Psychotic symptoms in the elderly: Prevalence in Alzheimer's Disease and nondemented individuals from a community-based sample in Brazil Imanari Ribeiz, Salma Rose
2009
5 4S p. P296
artikel
1342 Public support for an annual tax increase to provide access to an Alzheimer's disease medication in Canada Clayton, Natasha
2009
5 4S p. P326-P327
artikel
1343 Putative gamma secretase modulators lower Aβ42 in multiple in vitro and in vivo models Rogers, Kathryn
2009
5 4S p. P428-P429
artikel
1344 Pyroglutamate 3 Abeta immunoreactivity in brains of mice, monkeys and humans Lemere, Cynthia A.
2009
5 4S p. P75
artikel
1345 Pyroglutamate formation influences the solubility and amyloidogeneity of amyloid peptides Schilling, Stephan
2009
5 4S p. P75
artikel
1346 Qualitative analyses of clock drawings in mild cognitive impairment Ryu, Seon-Young
2009
5 4S p. P361
artikel
1347 Quality of life, depression and stress in caregivers of elderly with dementia in jalisco, mexico Arias-Merino, Elva Dolores
2009
5 4S p. P232
artikel
1348 Quality of life in dementia: Money matters Gallrach, Franziska
2009
5 4S p. P91
artikel
1349 Quantification of cholinergic degeneration and adult neurogenesis in TgCRND8 mice following treatment with scyllo-inositol (ELND005) Aubert, Isabelle
2009
5 4S p. P487-P488
artikel
1350 Quantification of CSF and blood alpha-synuclein as a diagnostic marker for synucleinopathies Mollenhauer, Brit
2009
5 4S p. P148
artikel
1351 Quantification of total α-synuclein in cerebrospinal fluid by ELISA: Cross-sectional investigation of subjects with dementia and parkinsonism Schlossmacher, Michael G.
2009
5 4S p. P166-P167
artikel
1352 Quantitative analysis of electroencephalography in patients with Alzheimer's disease and mild cognitive impairment Roh, Jee Hoon
2009
5 4S p. P361-P362
artikel
1353 Quantitative measurement of cerebral hypoperfusion and atrophy in Alzheimer's disease using MRI Vemuri, Prashanthi
2009
5 4S p. P78
artikel
1354 Quantitative T2-decay weighted MRI correlates with cognitive function Levy, Ory
2009
5 4S p. P212-P213
artikel
1355 Quetiapine prevents memory impairment, up-regulates Bcl-2 expression and attenuates oxidative stress in an APP/PS1 double transgenic mouse model of Alzheimer's disease He, Jue
2009
5 4S p. P322
artikel
1356 Rates of regional brain atrophy and gain in power for assessment of cognitive decline in clinical trials Schuff, Norbert
2009
5 4S p. P206
artikel
1357 Rates of regional brain atrophy and gain in power for assessment of cognitive decline in clinical trials Schuff, Norbert
2009
5 4S p. P39
artikel
1358 Ratio P-Tau/Ab42 discriminates Alzheimer’s disease from semantic dementia and frontotemporal dementia with high specificity De Souza, Leonardo C.
2009
5 4S p. P349
artikel
1359 Real-time PCR analysis of the cytokine expression profiles in nondemented patients with increasing Alzheimer's disease pathology Konishi, Yoshihiro
2009
5 4S p. P479
artikel
1360 Reassessment of APP Familial Alzheimer's Disease (FAD) mutations Munter, Lisa M.
2009
5 4S p. P117
artikel
1361 Recruiting for Alzheimer's disease Research: A systematic review of recruitment techniques and challenges among NIH-funded ADRCs Markgraf, Tamara S.
2009
5 4S p. P242-P243
artikel
1362 Reduced frontal oxygenation during a verbal fluency test in patients suffering from Alzheimer's disease B. M. Langer, Julia
2009
5 4S p. P268-P269
artikel
1363 Reduced frontal oxygenation during a verbal fluency test in patients suffering from Alzheimer's disease Langer, Julia B.M.
2009
5 4S p. P62
artikel
1364 Reduced neprilysin activity is associated with increased formation of pyroglutamylated amyloid-β peptides through upregulation of aminopeptidases and glutaminyl cyclase in brain Iwata, Nobuhisa
2009
5 4S p. P472-P473
artikel
1365 Reducing noise in the ADAS-COG wordlist task Shankle, William R.
2009
5 4S p. P161
artikel
1366 Reduction of cortical acetylcholine esterase in mild cognitive impairment: Consistency across centers and PET methods Herholz, Karl
2009
5 4S p. P366
artikel
1367 Reduction of cortical acetylcholine esterase in mild cognitive impairment: Consistency across centers and PET methods Herholz, Karl
2009
5 4S p. P22
artikel
1368 Regional changes in brain perfusion during REM sleep in patients with Alzheimer's disease Gabelle, Audrey
2009
5 4S p. P218
artikel
1369 Regional changes in brain perfusion during REM sleep in patients with Alzheimer's disease Gabelle, Audrey
2009
5 4S p. P57
artikel
1370 Regulation of gene expression by sAPPα and RER derivative in differentiated neuroblastoma cells Ryan, Margaret M.
2009
5 4S p. P421
artikel
1371 Regulation of GSK-3 by setα and its effect on abnormal hyperphosphorylation of tau Wang, Jian-Zhi
2009
5 4S p. P93
artikel
1372 Regulation of intracellular APP transport by X11L Shiono, Maki
2009
5 4S p. P485
artikel
1373 Regulation of pyroglutamyl amyloid beta peptide formation by neprilysin Saido, Takaomi C.
2009
5 4S p. P74-P75
artikel
1374 Regulator of calcineurin 1 (RCAN1) is degraded by ubiquitin-proteasome and chaperone-mediated autophagy pathway Sun, Xiulian
2009
5 4S p. P310
artikel
1375 Regulatory mechanisms of app and alcadein transport by kinesin-1 Araseki, Masahiko
2009
5 4S p. P224
artikel
1376 Relation between amyloid burden, brain atrophy and memory in Alzheimer's disease Bourgeat, Pierrick
2009
5 4S p. P76
artikel
1377 Relation between APOE ϵ4 allele and MCI is modulated by geographical region: Results from the DESCRIPA study Norberg, Jocke
2009
5 4S p. P362-P363
artikel
1378 Relation between blood pressure and cognition in a randomized, placebo-controlled, double-blind pilot study with soy isoflavones Wharton, Whitney
2009
5 4S p. P249-P250
artikel
1379 Relation of C-reactive protein to cognitive impairment Noble, James M.
2009
5 4S p. P297
artikel
1380 Relation of fasting plasma total cholesterol, triglycerides, and glucose, to Alzheimer's disease and vascular dementia: A community-based population study Ramdane, Said
2009
5 4S p. P280-P281
artikel
1381 Relationship between longitudinal telephone screening and neuropsychological test performance Ford, Alicia Ito
2009
5 4S p. P451-P452
artikel
1382 Relationship between patient dependence on others and caregiver burden in Alzheimer's Disease (AD) Lacey, Loretto A.
2009
5 4S p. P229-P230
artikel
1383 Relationship between regional amyloid levels and cognitive performance in healthy controls, MCI subjects, and patients with alzheimer's: Phase II results from a florpiramine F18 PET imaging study Doraiswamy, P Murali
2009
5 4S p. P77
artikel
1384 Relationship between the diagnostic components of metabolic syndrome (MS) and cognition by ApoE genotype in the elderly Hong, Chang Hyung
2009
5 4S p. P287
artikel
1385 Relationship of cerebrospinal fluid biomarkers with in vivo [11C]PIB and [18F]FDDNP binding van Berckel, Bart N.M.
2009
5 4S p. P137
artikel
1386 Relevance of computerized cognitive assessment to functional disability in a mildly impaired elderly cohort Simon, Ely S.
2009
5 4S p. P354
artikel
1387 Reliability and validity of the Caregiver-Perceived Burden Questionnaire (CPBQ) in Alzheimer's disease Haim Erder, M.
2009
5 4S p. P239-P240
artikel
1388 Rember: Issues in design of a phase 3 disease modifying clinical trial of Tau aggregation inhibitor therapy in Alzheimer's disease Wischik, Claude
2009
5 4S p. P74
artikel
1389 Remodeling hippocampal network excitability in mouse models of Alzheimer's Noebels, Jeffrey L.
2009
5 4S p. P69
artikel
1390 Repetitive transcranial magnetic stimulation (rTMS) in Alzheimer disease: New therapeutic perspectives Calabria, Marco
2009
5 4S p. P336
artikel
1391 Reproducibility in the assessment of Alzheimer's disease and Lewy body disease-related pathologies: A study by Brain Net Europe Alafuzoff, Irina I.
2009
5 4S p. P71
artikel
1392 Research on the actual condition for diagnoses and treatments of depression in patients with Alzheimer's disease and/or cerebrovascular disease in Japan Takahashi, Megumi
2009
5 4S p. P244
artikel
1393 Resolution of neuroinflammation by Cytochrome P4504f: Implication in Alzheimer's disease Sehgal, Neha
2009
5 4S p. P483
artikel
1394 Restorative effects of BDNF gene delivery into entorhinal cortex in APP transgenic mice Nagahara, Alan H.
2009
5 4S p. P324-P325
artikel
1395 Results of a double-blind phase 2b study of monthly mimopezil implants compared to oral donepezil in patients with moderate Alzheimer's disease (BRAINZ study) Wilkinson, David
2009
5 4S p. P85
artikel
1396 Results of the first-in-man study with the active Aβ Immunotherapy CAD106 in Alzheimer patients Winblad, Bengt G.
2009
5 4S p. P113-P114
artikel
1397 Results of the MIDAS trial: Effects of docosahexaenoic acid on physiological and safety parameters in age-related cognitive decline Yurko-Mauro, Karin
2009
5 4S p. P84
artikel
1398 Retiniod X Receptor As A Therapeutic Target For Alzheimer's Disease Cramer, Paige E.
2009
5 4S p. e9
artikel
1399 Retrieval and storage of episodic memory: Do differences exist between vascular dementia and Alzheimer's disease? Kandiah, Nagaendran
2009
5 4S p. P454
artikel
1400 Review of end point in preventive trials Andrieu, Sandrine
2009
5 4S p. P143
artikel
1401 Right hemispheric lesions may affect over self-estimation of daily activities in patients with vascular dementia Tezuka, Kimihiro
2009
5 4S p. P453
artikel
1402 Risk alleles, DNA methylation and gene expression Singleton, Andrew
2009
5 4S p. P169
artikel
1403 Risk factors for cognitive function after a 7 year follow up in a population-based study: The Tromsø study Arne Arntzen, Kjell
2009
5 4S p. P383
artikel
1404 Risk for Earlier Age of Onset in LOAD: The Impact of History of Alcohol Abuse Cuccaro, Michael
2009
5 4S p. P286
artikel
1405 Risk of dementia continues to rise in the oldest old: The Monzino 80-plus Study Lucca, Ugo
2009
5 4S p. P381
artikel
1406 Risk of nursing home placement in dementia with Lewy bodies and Alzheimer's dementia Rongve, Arvid
2009
5 4S p. P79
artikel
1407 Robust automatic segmentation of hippocampus from multisite MRI data Collins, D. Louis
2009
5 4S p. P103
artikel
1408 Role of Abca1, ApoE and ApoA-I in Alzheimer's disease pathogenesis: Lessons from complex animal models Lefterov, Iliya
2009
5 4S p. P168
artikel
1409 Role of BDNF val66met polymorphism on the association between physical activity and incident dementia Kim, Jae-Min
2009
5 4S p. P469
artikel
1410 Role of memory span and speed decline in several language measures in healthy elderly people and Alzheimer's disease Facal, David
2009
5 4S p. P409
artikel
1411 Role of PP2A methylation pathways in tau regulation Sontag, Estelle
2009
5 4S p. P94
artikel
1412 Role of pyro-Glu Abeta in AD Demuth, Hans-Ulrich
2009
5 4S p. P119-P120
artikel
1413 Role of the genetic background in the neurodegeneration induced by truncated tau in the transgenic rat model Stozicka, Zuzana
2009
5 4S p. P445
artikel
1414 Role of the LRP-RanBP9 pathway in APP processing and Alzheimer's disease susceptibility Kang, David E.
2009
5 4S p. P151-P152
artikel
1415 Route-learning impairment is highly sensitive and specific to Alzheimer's disease Nestor, Peter J.
2009
5 4S p. P449
artikel
1416 Rubidium is altered from early stages of AD: A postmortem study using neutron activation analysis Leite, Renata E.P.
2009
5 4S p. P279
artikel
1417 Saccadic eye movements in Alzheimer's disease and mild cognitive impairment Garcia, Angeles
2009
5 4S p. P364
artikel
1418 S-adenosylmethionine contrasts multiple Alzheimer-like features induced by B-vitamin deficiency in TgCRND8 mice Scarpa, Sigfrido
2009
5 4S p. P485-P486
artikel
1419 Safety and efficacy of a galantamine/memantine combination in mild to moderate Alzheimer's disease - randomized controlled trial Peters, Oliver
2009
5 4S p. P86-P87
artikel
1420 Safety and efficacy of tarenflurbil in subjects with mild Alzheimer's disease: Results from an 18-month international multi-center phase 3 trial Wilcock, Gordon K.
2009
5 4S p. P86
artikel
1421 Safety and pharmacokinetics of the anti-amyloid monoclonal antibody PF-04360365 following a single infusion in patients with mild-to-moderate Alzheimer's disease: Preliminary results Bednar, Martin
2009
5 4S p. P157
artikel
1422 Safety and tolerability of rosiglitazone XR in a randomised, placebo-controlled study in APOE4-stratified subjects with mild-to-moderate Alzheimer's disease Zvartau-Hind, Marina
2009
5 4S p. P248
artikel
1423 Safety, tolerability and pharmacokinetics of SUVN-502 - A 5-HT6 receptor antagonist, first in human phase-1 Single Ascending Dose (SAD) study Nirogi, Ramakrishna
2009
5 4S p. P250
artikel
1424 Scandinavian multidomain interventions Ahtiluoto, Satu
2009
5 4S p. P145
artikel
1425 Screening cognitive impairments based on elders' performance in learning digital instruments Xavier, André Junqueira
2009
5 4S p. P132
artikel
1426 Screening dementia in low SES communities in Brazil: the Sao Paulo Ageing & Health study. Scazufca, Marcia
2009
5 4S p. P122
artikel
1427 Screening for Alzheimer's Disease: Health Economic Projections of the Impact of Earlier Diagnosis and Treatment Maclaine, Grant
2009
5 4S p. P274-P275
artikel
1428 Screening for dementia in New York and Kerala, India Verghese, Joe
2009
5 4S p. P121
artikel
1429 Screening of Alzheimer's disease in elderly diabetes using self-reported questionnaire and physical parameters Sakurai, Takashi
2009
5 4S p. P188
artikel
1430 scyllo-inositol (ELND005) ameliorates amyloid pathology in an aggressive mouse model of Alzheimer's disease DaSilva, Kevin A.
2009
5 4S p. P425
artikel
1431 Secondary endpoint and responder analyses in a study of rosiglitazone XR in APOE4-stratified subjects with mild-to-moderate Alzheimer's disease Alderton, Claire
2009
5 4S p. P254
artikel
1432 γ-secretase inhibitor, but not modulator, causes Aβ overshoot and accumulation of β-CTF Matsuoka, Yasuji
2009
5 4S p. P422
artikel
1433 γ-Secretase substrates APP, Notch1 and CD44 show distinct processing in NPC cells Malnar, Martina
2009
5 4S p. P223-P224
artikel
1434 Secular trends in cognitive performance in relation to prediction of dementia Sacuiu, Simona
2009
5 4S p. P130-P131
artikel
1435 Selection of an anti-Abeta antibody that binds various forms of Abeta and blocks toxicity both in vitro and in vivo Watts, Ryan J.
2009
5 4S p. P426
artikel
1436 Selective axonal damage and long-term spatial reference memory deficits after mild fluid percussion injury in mice Fowler, Jill H.
2009
5 4S p. P298
artikel
1437 Selective increase in neuronal activity in the vicinity of amyloid plaques in a mouse model of Alzheimer's disease Garaschuk, Olga
2009
5 4S p. P120
artikel
1438 Selective modulation of Ab42 by calcium channel antagonists. Relevance of calcium dynamics D'Arrigo, Antonello
2009
5 4S p. P420-P421
artikel
1439 Selective targeting of perivascular macrophages for β-amyloid clearance in cerebral amyloid angiopathy McLaurin, JoAnne
2009
5 4S p. P152
artikel
1440 Serial FDG and PiB PET in cognitive impairment Lowe, Val
2009
5 4S p. P126
artikel
1441 Serum Metabolite Biomarkers In Alzheimer's Disease Purandare, Nitin
2009
5 4S p. e21
artikel
1442 Serum progranulin is reduced in GRN mutation carriers but not in other dementia Hsiung, Ging-Yuek R.
2009
5 4S p. P342
artikel
1443 Serum Progranulin levels in the diagnosis of Progranulin-related neurodegenerative diseases Sleegers, Kristel
2009
5 4S p. P95
artikel
1444 Severe Psychological Stress In The Elderly: A Proposed Model Of Neurodegeneration Tsolaki, Magda
2009
5 4S p. e23
artikel
1445 Severity of mild cognitive impairment is a predictor of conversion to dementia: The canton ticino study Quadri, Pierluigi
2009
5 4S p. P360
artikel
1446 Sex-specific Metabolic Decline Of Temporal Lobe Regions In Alzheimer's Disease (ad) Wong, Thalia
2009
5 4S p. e18
artikel
1447 Shanghai community brain health initiative: Pilot study. Neuropsychological results Zhao, Qianhua
2009
5 4S p. P376
artikel
1448 Shanghai community brain health initiative pilot study: Neuropsychological results Zhao, Qianhua
2009
5 4S p. P14-P15
artikel
1449 Shanghai community brain health initiative (scobhi) pilot study: apoe findings Borenstein, Amy R.
2009
5 4S p. P282
artikel
1450 Shanghai community brain health initiative (scobhi) pilot study: methods and participation rates Borenstein, Amy R.
2009
5 4S p. P281
artikel
1451 Short-term spatial memory is impaired in early Alzheimer's disease but not in temporal variant frontotemporal lobar degeneration Chan, Dennis
2009
5 4S p. P160
artikel
1452 Side effects of Rivastigmine (Exelon) transdermal patch Tsolaki, Magda
2009
5 4S p. P334
artikel
1453 SIGMAR1 Association Analysis With Dementia And Parkinsonism Phenotypes Dobson-Stone, Carol
2009
5 4S p. e19
artikel
1454 Significantly altered BACE1 levels have been found in the blood of Alzheimer's disease and MCI subjects Shen, Yong
2009
5 4S p. P134
artikel
1455 Silver nanoparticles as alternate strategies for drug delivery to Alzheimer brain Aliev, Gjumrakch
2009
5 4S p. P324
artikel
1456 Silver nanoparticles as alternate strategies for drug delivery to the Alzheimer brain Aliev, Gjumrakch
2009
5 4S p. P65
artikel
1457 Similarity in patterns of white matter integrity alteration between healthy ApoE-4 carriers and Alzheimer's disease patients Zhan, Wang
2009
5 4S p. P112
artikel
1458 Simvastatin improves cerebrovascular function and reduces soluble amyloid-beta, inflammation and oxidative stress in aged APP mice Tong, Xinkang
2009
5 4S p. P331
artikel
1459 Single chain variable fragment against nicastrin inhibits the γ-secretase activity Tomita, Taisuke
2009
5 4S p. P87-P88
artikel
1460 Sirtuin signaling in Alzheimer's disease Gan, Li
2009
5 4S p. P120
artikel
1461 Six months of controlled aerobic exercise reduces cortisol for women but not men with MCI Baker, Laura D.
2009
5 4S p. P334
artikel
1462 Smoking effects on mortality and dementia: Radiation Effects Research Foundation Adult Health Study Yamada, Michiko
2009
5 4S p. P283
artikel
1463 SNPs in catalytic and regulatory subunits of calcineurin are associated with CSF tau levels and mRNA levels Cruchaga, Carlos
2009
5 4S p. P471-P472
artikel
1464 Social impact in the measurement of clinically meaningful change: Findings from the cross-sectional validation of the Clinical Meaningfulness in Alzheimer Disease Treatment (CLIMAT) scale Jacova, Claudia
2009
5 4S p. P189
artikel
1465 Soluble hyper-phosphorylated tau disrupts the microtubule-binding function of normal tau in vivo Cowan, Catherine M.
2009
5 4S p. P135-P136
artikel
1466 Some highlights of the Australian Dementia Outcomes Measurement Suite (DOMS) project: Social isolation Sansoni, Jan
2009
5 4S p. P90
artikel
1467 SORLA controls APP-dependent stimulation of ERK signaling and adult neurogenesis Rohe, Michael S.
2009
5 4S p. P174
artikel
1468 Spanish translation and normative data for the Dementia Rating Scale, second edition Strutt, Adriana M.
2009
5 4S p. P451
artikel
1469 Specific APP translation blockers as a therapeutic intervention for Alzheimer's disease Rogers, Jack T.
2009
5 4S p. P138-P139
artikel
1470 Specific detection of soluble amyloid beta oligomers using conformationally dynamic pronucleon™ peptides Moll, Jonathan R.
2009
5 4S p. P193-P194
artikel
1471 Specificity of available structural markers on MRI Scheltens, Philip
2009
5 4S p. P99
artikel
1472 Specificity Of The Anti-inflammatory Drug Cni-1493 Over Amyloid Beta Species And The Cell Type Balakrishnan, Karthikeyan
2009
5 4S p. e8
artikel
1473 Specific support services needed by caregivers of patients with mild cognitive impairment Ryan, Kelly A.
2009
5 4S p. P230
artikel
1474 Spectrum of dementia in North Indian population Pradhan, Sunil
2009
5 4S p. P191
artikel
1475 Spousal dementia caregiving as a risk factor for incident dementia Norton, Maria C.
2009
5 4S p. P380-P381
artikel
1476 Stated preference methods in questionable dementia evaluation: an emerging methodological paradigm in health economics Prolo, Paolo
2009
5 4S p. P239
artikel
1477 Statins and dementia prevention: A population-based study (FINRISK) Solomon, Alina
2009
5 4S p. P292
artikel
1478 Statin Use Is Not Associated With Cognitive Impairment In A Cohort of Older Women Schneider, Eric B.
2009
5 4S p. e13-e14
artikel
1479 Statistical properties of maps of regional cerebral blood flow generated by continuous arterial spin labeling Becker, James T.
2009
5 4S p. P31
artikel
1480 Statistical recognition pattern of EEG in diagnosis of Alzheimer's disease Snaedal, Jon
2009
5 4S p. P261
artikel
1481 Statistical recognition pattern of EEG in diagnosis of Alzheimer's disease Snaedal, Jon
2009
5 4S p. P48-P49
artikel
1482 Stereological investigation of the hippocampus of amyloid beta (1-42)- induced Alzheimer's rat model Singh, Prabhakar
2009
5 4S p. P180
artikel
1483 Stereospecific interactions are necessary for Alzheimer's disease amyloid-beta toxicity Ciccotosto, Giuseppe D.
2009
5 4S p. P492-P493
artikel
1484 Stimulation of platelet-secreted amyloid peptides by Ca2+and prostaglandin 2 Smirnov, Alexander
2009
5 4S p. P174
artikel
1485 Stimulus-selective neuromodulatory action of beta-amyloid Govoni, Stefano
2009
5 4S p. P179-P180
artikel
1486 Stressed astrocytes: A new player in apoE4-associated Alzheimer's disease Weisgraber, Karl H.
2009
5 4S p. P109
artikel
1487 Strong parenchymal amyloid reduction following CAD106 immunotherapy is associated with an increase in vascular Aβ but not microhemorrhages Staufenbiel, Matthias
2009
5 4S p. P114
artikel
1488 Structural and functional analysis of γ-secretase and its protease active site domain Steiner, Harald
2009
5 4S p. P87
artikel
1489 Structural and functional Golgi defects in Alzheimer's disease Wang, Yanzhuang
2009
5 4S p. P88
artikel
1490 Structural dynamics of the transmembrane domain of the amyloid precursor protein (APP) determined by deuterium/hydrogen exchange Pester, Oxana
2009
5 4S p. P485
artikel
1491 Structural requirements for APP processing by γ-secretase Kienlen-Campard, Pascal
2009
5 4S p. P87
artikel
1492 Structure and function of alpha-synuclein Eliezer, David
2009
5 4S p. P124
artikel
1493 Studies on the mechanism of soluble-RAGE generation from full-length RAGE Mook-Jung, Inhee
2009
5 4S p. P479-P480
artikel
1494 Studying the oldest old Kawas, Claudia H.
2009
5 4S p. P96-P97
artikel
1495 Study of the usefulness of the Korean story recall test in patients with Alzheimer's disease Baek, Min J.
2009
5 4S p. P239
artikel
1496 Study on the performance of behavioural assessment of the dysexecutive syndrome (BADS) in healthy individuals, mild cognitive impairment and Alzheimer's disease Armentano, Cristiane G.C.
2009
5 4S p. P450
artikel
1497 Sub-clinical Zinc Deficiency Found In Alzheimer's Disease Brewer, George
2009
5 4S p. e22
artikel
1498 Subcortical fiber tract integrity and the CERAD cognitive battery in patients with Alzheimer's disease: A multivariate approach to detect morphological correlates of cognitive failure Wagner, Maximilian
2009
5 4S p. P268
artikel
1499 Subcortical fiber tract integrity and the CERAD cognitive battery in patients with Alzheimer's disease: A multivariate approach to detect morphological correlates of cognitive failure Wagner, Maximilian
2009
5 4S p. P61-P62
artikel
1500 Subhippocampal dysfunction as a clinical marker of incipient Alzheimer's disease Didic Hamel Cooke, Mira
2009
5 4S p. P161
artikel
1501 Subregion-specific vulnerability to endoplasmic reticulum stress-induced neurotoxicity in rat hippocampal neurons Ishige, Kumiko
2009
5 4S p. P310
artikel
1502 Subscriber information page 2009
5 4S p. A1
artikel
1503 Substrate requirements and mechanisms of intramembrane proteolysis by gamma-secretase and related proteases Haass, Christian
2009
5 4S p. P226
artikel
1504 Subtypes of MCI and their progression to particular types of dementia: A community-based prospective neuro-imaging study Kida, Jiro
2009
5 4S p. P358
artikel
1505 Subtypes of MCI and their progression to particular types of dementia: A community-based prospective neuro-imaging study Kida, Jiro
2009
5 4S p. P11-P12
artikel
1506 Successful brain aging in a cohort of oldest old in Brazil: The Pietà study Barbosa, Maira T.
2009
5 4S p. P392
artikel
1507 Successful memory retrieval requires increased parietal activity in asymptomatic older adults with high amyloid burden Vannini, Patrizia
2009
5 4S p. P100
artikel
1508 Succinyl phosphonate, a protector of the 2-oxoglutarate dehydrogenase complex, corrects behavioral impairments in rats exposed to hypoxia or ethanol Bunik, Victoria I.
2009
5 4S p. P476-P477
artikel
1509 Surgery using general anesthesia and risk of dementia in the Aging, Demographics and Memory Study Plassman, Brenda L.
2009
5 4S p. P389
artikel
1510 Survival, apoptosis and characterization of TDP-43 in cells derived from progranulin knockout mice Kleinberger, Gernot
2009
5 4S p. P444-P445
artikel
1511 Suspected Alzheimer's disease with negative pittsburgh compound-B positron emission tomography Lee, Jae-Hong
2009
5 4S p. P215
artikel
1512 Sustained Interleukin-1 expression drives plaque clearance in a mouse model of Alzheimer's disease O'Banion, M.K.
2009
5 4S p. P483-P484
artikel
1513 SUVN-502: A safe, potent, selective, brain penetrant and orally active 5-HT6 receptor antagonist - first in human clinical phase-1 study Nirogi, Ramakrishna
2009
5 4S p. P250
artikel
1514 Swimming training-to-criterion and pre-exposure to MWM are required for complete restoration of learning in APP transgenic mice carrying a mutation in Asp664 Zhang, Junli
2009
5 4S p. P438
artikel
1515 Symptoms of apathy and depression and the validity of the Audio Recorded Cognitive Screen (ARCS) Schofield, Peter W.
2009
5 4S p. P453-P454
artikel
1516 Synaptic activity reduces intraneuronal Aβ, alters APP transport and protects against Alzheimer's disease-like synaptic alterations Tampellini, Davide
2009
5 4S p. P116
artikel
1517 Synaptic-dependent release of amyloid-beta in vivo Cirrito, John R.
2009
5 4S p. P70
artikel
1518 Synaptic α-synuclein aggregates may explain neurodegeneration in DLB Schulz-Schaeffer, Walter
2009
5 4S p. P124
artikel
1519 Synergism between the CCR5Δ32 deletion and APOEϵ4 polymorphisms in vascular and mixed dementia of the very old Zekry, Dina
2009
5 4S p. P461
artikel
1520 Synergistic treatment effects with Cerebrolysin and donepezil: Results from a randomized, double-blind, multicenter trial to compare safety and efficacy of Cerebrolysin, donepezil and a combination treatment in patients with probable Alzheimer's disease Doppler, Edith
2009
5 4S p. P248-P249
artikel
1521 Synthesis And Characterization Of Fluorinated Magnetic Core-shell Nanoparticles For Inhibition Of Insulin Amyloid Fibril Formation Skaat, Hadas
2009
5 4S p. e14
artikel
1522 Synthetic Abeta 1-40 oligomers impair recognition memory in mice Balducci, Claudia
2009
5 4S p. P182
artikel
1523 Synthetic Abeta 1-40 oligomers impair recognition memory in mice Balducci, Claudia
2009
5 4S p. P7
artikel
1524 Systematic identification of proteases with alpha-secretase activity Lichtenthaler, Stefan F.
2009
5 4S p. P474-P475
artikel
1525 Systematic review and collaborative analysis of the prevalence of dementia in Europe Reynish, Emma
2009
5 4S p. P393
artikel
1526 Systematic review and meta-analysis of the accuracy of the eurotest for the detection of dementia Espejo-Martinez, Beatriz
2009
5 4S p. P447
artikel
1527 TANDEM: Communication Trainings for caregivers of dementia patients Krause, Katharina
2009
5 4S p. P242
artikel
1528 Targeting the APP secretases improves learning and reduces hippocampal cell death following brain injury Burns, Mark P.
2009
5 4S p. P89
artikel
1529 Tau and Alzheimer's disease: From structure to transgenic mice and aggregation inhibitors Mandelkow, Eckhard
2009
5 4S p. P92
artikel
1530 Tau contributes to GSK3 induced hippocampal degeneration and learning deficits that are reduced in tau k.o. mice de Barreda, Elena Gómez
2009
5 4S p. P404-P405
artikel
1531 Tau extraction with perchloric acid preserves its structure and phosphorylation pattern Ivanovova, Natalia
2009
5 4S p. P402
artikel
1532 Tau-induced microtubules polarity reorientation rather than depolymerization leads to axonal traffic jams, ultrastructural modifications and neurodegeneration Shemesh, Or A.
2009
5 4S p. P399
artikel
1533 Tau protein antagonizes cell apoptosis through Akt pathway Jun, Yin
2009
5 4S p. P309-P310
artikel
1534 Tau protein interaction with M1 and M3 muscarinic receptors Rubio, Alicia
2009
5 4S p. P404
artikel
1535 Tau vaccine: Active immunization with misfolded tau protein attenuates tau pathology in the transgenic rat model of tauopathy Novak, Michal
2009
5 4S p. P93
artikel
1536 TDP-43 and beta-amyloid precursor protein processing products in cerebrospinal fluid of patients with amyotrophic lateral sclerosis and frontotemporal lobar degeneration Otto, Markus
2009
5 4S p. P162
artikel
1537 TDP-43 deposition in presenilin mutation-associated Alzheimer's, sporadic Alzheimer's, and non-demented elderly Leverenz, James B.
2009
5 4S p. P108
artikel
1538 Telomere Shortening Abrogates Dentate Gyrus Neurogenesis But Improves Alzheimer'S Disease Progression In Mice Suresh, Harshvardhan
2009
5 4S p. e19
artikel
1539 Temporal orientation is the best discriminative item of the Folstein's Mini Mental Status Examination d'Orsi, Eleonora
2009
5 4S p. P275
artikel
1540 Temporal profile for amyloid precursor protein, amyloid-β and tau expression in primary cultures from 3xTg-AD mice Llort, Lydia Gimenez
2009
5 4S p. P441
artikel
1541 Tensor-based morphometry as surrogate marker for Alzheimer's disease and mild cognitive impairment: Optimizing statistical power Thompson, Paul
2009
5 4S p. P36
artikel
1542 Tensor-based morphometry as surrogate marker for Alzheimer's disease and mild cognitive impairment: optimizing statistical power Thompson, Paul
2009
5 4S p. P204-P205
artikel
1543 Testing for association between Alzheimer's disease and known susceptibility variants for type 2 diabetes Stretton, Alexandra
2009
5 4S p. P466
artikel
1544 Testing the amyloid cascade hypothesis in a novel mouse model of Alzheimer's disease that shows complete disease progression Colton, Carol A.
2009
5 4S p. P82-P83
artikel
1545 Test-retest variability studies in Alzheimer's disease and normal ageing of the new amyloid imaging agent [18F]BAY 94-9172 C. Rowe, Christopher
2009
5 4S p. P262-P263
artikel
1546 The Abeta Oligomer Selective Antibody Nab61 Recognizes Abeta Oligomers In The AD And APP Transgenic Mouse Brains And Neutralizes Abeta Mediated Synaptic Dysfunction Lundkvist, Johan
2009
5 4S p. e11
artikel
1547 The ADAS-cog's performance as a measure - lessons from the ADNI study: Part 3 - do the scale modifications add value? Hobart, Jeremy
2009
5 4S p. P256
artikel
1548 The ADAS-cog's performance as a measure—lessons from the ADNI study: Part 2 - evaluation using modern psychometric methods Cano, Stefan
2009
5 4S p. P158
artikel
1549 The ADAS-cog's performance as a measure - lessons from the ADNI study: Part 1 - evaluation using traditional psychometric methods Posner, Holly
2009
5 4S p. P256
artikel
1550 The ADCS valproate neuroprotection trial: Primary efficacy and safety results Tariot, Pierre N.
2009
5 4S p. P84-P85
artikel
1551 The ADNI multicenter study: CSF biomarkers data report Shaw, Leslie M.
2009
5 4S p. P94-P95
artikel
1552 The AIBL study: Baseline data from a multicenter, prospective longitudinal study of ageing in 1,100 volunteers Szoeke, Cassandra
2009
5 4S p. P10
artikel
1553 The AIBL study: Baseline data from a multicenter, prospective longitudinal study of ageing in 1,100 volunteers Szoeke, Cassandra
2009
5 4S p. P184-P185
artikel
1554 The Alzheimer's Disease Caregiver Questionnaire (ADCQ): Initial validation of an informant-completed screening instrument for Mild Cognitive Impairment (MCI) Murphy, Cynthia A.
2009
5 4S p. P447
artikel
1555 The amyloid-GSK3-tau connection to neurodegeneration revealed by combining transgenic and viral models Van Leuven, Fred
2009
5 4S p. P135
artikel
1556 The Anti-inflammatory Drug Cni-1493 Decreases The Toxic Amyloid Oligomers And Induces Neuro-protective Effect In App Transgenic Mice Balakrishnan, Karthikeyan
2009
5 4S p. e7-e8
artikel
1557 The anxiogenic effects of Abeta (1- 40) and Abeta (1-42) in the dorsal raphe nucleus in male rats Gholizadeh, Shervin
2009
5 4S p. P304-P305
artikel
1558 The application of partial-volume correction to Alzheimer's disease discrimination Thomas, Benjamin A.
2009
5 4S p. P20-P21
artikel
1559 The Association Between Pre-morbid Personality Disorder And Alzheimer'S Disease Husain, Muhammad I.
2009
5 4S p. e29
artikel
1560 The association between vascular risk factors and Korean Alzheimer's disease patients Kang, Hee Jin
2009
5 4S p. P388-P389
artikel
1561 The association of cognitive dysfunction and osteoporosis in old age Park, Moon Ho
2009
5 4S p. P283
artikel
1562 The association of frailty with cognitive impairment in a cohort of community living older people Kurrle, Susan
2009
5 4S p. P504
artikel
1563 The barriers to the early diagnosis of dementia and diagnostic disclosure in primary care Paterson, Nerida E.
2009
5 4S p. P185
artikel
1564 The bimodality of healthy ageing: How do the differing profiles of healthy controls compare to patients with mild cognitive impairment? Ames, David J.
2009
5 4S p. P14
artikel
1565 The bimodality of healthy ageing: How do the differing profiles of healthy controls compare to patients with mild cognitive impairment? Ames, David J.
2009
5 4S p. P375-P376
artikel
1566 The biological effects of R278I-Presenilin-1 familial mutation on γ-secretase activity and amyloid pathology Saito, Takashi
2009
5 4S p. P446
artikel
1567 The changing of distribution and location of neuroglobin in Tg2576 transgenic mouse Chen, Zliming
2009
5 4S p. P43
artikel
1568 The changing of distribution and location of neuroglobin in Tg2576 transgenic mouse Chen, Liming
2009
5 4S p. P222
artikel
1569 The choroid plexus is involved in antibody-induced beta-amyloid clearance Du, Yansheng
2009
5 4S p. P182-P183
artikel
1570 The clinical characteristics of the Japanese pedigree of FAD with PS1 H163R mutation Miyagawa, Toji
2009
5 4S p. P186-P187
artikel
1571 The cognitive reserve hypothesis in a population with low education Farfel, Jose M.
2009
5 4S p. P108-P109
artikel
1572 The concept of the new criteria: “Opening the window” Dubois, Bruno
2009
5 4S p. P99
artikel
1573 The correlation of daily living activities and cognition of dementia subtypes Ozge, Aynur
2009
5 4S p. P189
artikel
1574 The dementia difference: Practice changes after a workshop for staff on caring for people dying with Alzheimer's disease Robinson, Janice G.
2009
5 4S p. P141
artikel
1575 The deposition of Aß40 in the brain is pathognomonic for Alzheimer-type dementia in Down syndrome Pesini, Pedro
2009
5 4S p. P297-P298
artikel
1576 The disruption of A-Beta peptide by transthyretin: A mechanism sensitive to Kunitz Protease Inhibitor Costa, Rita
2009
5 4S p. P476
artikel
1577 The dysregulation of the G1/S transition point in Alzheimer's disease Nagy, Zsuzsanna
2009
5 4S p. P171
artikel
1578 The Effect Of Aging On Cognition Of Amnestic Type Of Mild Cognitive Impairment And Early Alzheimer's Disease Katayama, Sadao
2009
5 4S p. e10-e11
artikel
1579 The effect of chronic cerebral hypoperfusion on clearance and production of β-amyloid peptide Li, Liang
2009
5 4S p. P280
artikel
1580 The effect of chronic cerebral hypoperfusion on clearance and production of β-amyloid peptide Li, Liang
2009
5 4S p. P37
artikel
1581 The effect of donepezil on the reactions of the innate immune system in the peripheral blood leukocytes of healthy young blood donors Leszek, Jerzy W.
2009
5 4S p. P320-P321
artikel
1582 The effect of head positioning and repositioning on SIENA-generated measures of brain volume change: Results from actual Z-shifts Caramanos, Zografos
2009
5 4S p. P266
artikel
1583 The effect of head positioning and repositioning on SIENA-generated measures of brain volume change: Results from actual Z-shifts Caramanos, Zografos
2009
5 4S p. P54
artikel
1584 The effect of head positioning and repositioning on SIENA-generated measures of brain volume change: Results from simulated Z-shifts Caramanos, Zografos
2009
5 4S p. P55
artikel
1585 The effect of head positioning and repositioning on SIENA-generated measures of brain volume change: Results from simulated Z-shifts Caramanos, Zografos
2009
5 4S p. P266-P267
artikel
1586 The effect of scyllo-inositol derivatives on β-amyloid peptide aggregation Hawkes, Cheryl
2009
5 4S p. P419
artikel
1587 The effect of the PPAR gamma agonist rosiglitazone on age-related changes in grey matter magnetic resonance relaxometry in the rat Blau, Christoph W.
2009
5 4S p. P7-P8
artikel
1588 The effect of the PPAR gamma agonist rosiglitazone on age-related changes in grey matter magnetic resonance relaxometry in the rat Blau, Christoph W.
2009
5 4S p. P207-P208
artikel
1589 The effect of Tubulin Polymerisation Promoting Protein (TPPP/p25) overexpression on the aggregation of alpha-synuclein Botond, Gergo
2009
5 4S p. P486
artikel
1590 The effects of beta amyloid treatment on VDR expression in primary cultured cortical neurons Dursun, Erdinc
2009
5 4S p. P491-P492
artikel
1591 The effects of diabetes mellitus on neuropathologic findings at autopsy: The Vantaa 85+ Study Kivipelto, Miia
2009
5 4S p. P123
artikel
1592 The effects of donepezil on apathy in patients with Alzheimer's disease Waldemar, Gunhild
2009
5 4S p. P408-P409
artikel
1593 The effects of galantamine and rivastigmine on cardiac electrophysiology in patients with Alzheimer's disease Turan Isik, Ahmet
2009
5 4S p. P339
artikel
1594 The effects of spelling the word “world” backward on total score of MMSE Midi, Ipek
2009
5 4S p. P192-P193
artikel
1595 The effects of verbal motor slowing on word duration and reaction time in Alzheimer's disease Midi, Ipek
2009
5 4S p. P192
artikel
1596 The effects of vitamin D on primary cortical and hippocampal neuron cultures Gezen-Ak, Duygu
2009
5 4S p. P491
artikel
1597 The efficacy of a medical food (Souvenaid®) in Alzheimer's disease: Results from the first trial and design of future trials Scheltens, Philip
2009
5 4S p. P258-P259
artikel
1598 The environment, epigenetics and amyloidogenesis Zawia, Nasser H.
2009
5 4S p. P147
artikel
1599 The ER stress transcription factor XBP1s protects against amyloid-beta neurotoxicity Fernandez-Funez, Pedro
2009
5 4S p. P497
artikel
1600 The exploration of predictive factors of burnout among caregivers of patients with dementia Takai, Michiko
2009
5 4S p. P229
artikel
1601 The Factorial Structure Of The Mini Mental State Examination (mmse) In Japanese Setting Shigemori, Kenta
2009
5 4S p. e14
artikel
1602 The first 3rd generation Alzheimer mouse, PLB1: Design and development Platt, Bettina
2009
5 4S p. P156
artikel
1603 The first third-generation Alzheimer mouse, PLB1: A 18F-FDG-PET study Mingarelli, Marco
2009
5 4S p. P436-P437
artikel
1604 The first Third-generation Alzheimer mouse, PLB1: An 18F-FDG-PET study Mingarelli, Marco
2009
5 4S p. P7
artikel
1605 The first third-generation Alzheimer mouse, PLB1: Assessment of spatial learning and memory in the water maze Ryan, Duncan
2009
5 4S p. P437-P438
artikel
1606 The first third-generation Alzheimer mouse, PLB1: EEG and activity behaviour Plano, Andrea
2009
5 4S p. P437
artikel
1607 The first third-generation Alzheimer mouse, PLB1: Electrophysiological characterization Drever, Benjamin D.
2009
5 4S p. P432
artikel
1608 The first third-generation Alzheimer mouse, PLB1: Learning and memory in the social interaction and recognition paradigm Merrick, Georgina
2009
5 4S p. P433
artikel
1609 The first third-generation Alzheimer mouse, PLB1: Motor performance and anxiety assessment Utan, Aneli
2009
5 4S p. P432
artikel
1610 The first third-generation Alzheimer mouse, PLB1: Tissue analyses and histology Koss, David J.
2009
5 4S p. P433
artikel
1611 The four repeat tau isoform 5 represents a calcium-dependent interaction partner of secretagogin (SCGN) Maj, Magdalena
2009
5 4S p. P400
artikel
1612 The frequency of ApoE2 is increased in asymptomatic Alzheimer's: The Nun Study cohort Iacono, Diego
2009
5 4S p. P470
artikel
1613 The functional impact of cerebral white matter hyperintensities in the elderly Murray, Melissa E.
2009
5 4S p. P10-P11
artikel
1614 The GAB2 gene and the risk of Alzheimer's disease: Replication and meta-analysis Ikram, Mohammad A.
2009
5 4S p. P462
artikel
1615 The Ginkgo in Evaluation of Memory (GEM) study: Lessons learned for planning future dementia primary prevention trials Williamson, Jeff D.
2009
5 4S p. P144
artikel
1616 The human body is an organism capable of using H2O as an electron source, like vegetables are: An unexpected finding with important therapeutic implications in AD Solis-Herrera, Arturo
2009
5 4S p. P320
artikel
1617 The hypothalamus in Alzheimer's disease: A study with silver impregnation techniques and electron microscope Baloyannis, Stavros I.
2009
5 4S p. P299
artikel
1618 The hypothalamus in Alzheimer's disease: A study with silver impregnation techniques and electron microscope Baloyannis, Stavros I.
2009
5 4S p. P40
artikel
1619 The image of patients and caregivers in the social perception of Alzheimer's disease - results from a literature review and a qualitative study considered with this target Pin Le Corre, Stéphanie
2009
5 4S p. P233
artikel
1620 The impact of ApoE on cognition and behavior Raber, Jacob
2009
5 4S p. P168
artikel
1621 The impact of changes in physical activity levels on rate of cognitive decline in a biracial cohort of non-demented elders Barnes, Deborah E.
2009
5 4S p. P104-P105
artikel
1622 The impact of disclosing a diagnosis of Alzheimer's disease Vista, Marco
2009
5 4S p. P236
artikel
1623 The impact of vascular and Alzheimer pathologies in Lewy body disease Jellinger, Kurt A.
2009
5 4S p. P163-P164
artikel
1624 The influence of education and ethnicity on Mini Mental State Examination (MMSE) scores Khan, Katija
2009
5 4S p. P454
artikel
1625 The influence of lipid profile on neuropsychological test in community-dwelling normal elders Moon, Seok Woo
2009
5 4S p. P455
artikel
1626 The interactions of trospium and galantamine with late onset Alzheimer disease and urinary incontinence Isik, Ahmet Turan
2009
5 4S p. P329
artikel
1627 The “LEARn” (Latent Early-life Associated Regulation) model may explain the etiology of sporadic cases of Alzheimer's disease Lahiri, Debomoy K.
2009
5 4S p. P146
artikel
1628 The longitudinal follow up of ‘Saving appearances answer’ among patients with dementia Takahashi, Satoshi
2009
5 4S p. P375
artikel
1629 The measurement of Everyday Cognition (ECog): Development and validation of a short version Mungas, Dan
2009
5 4S p. P192
artikel
1630 The Memory and Attention Test (MAT): Evaluation of an adaptive, computer-based performance test for early recognition and treatment evaluation in dementia Adler, Georg
2009
5 4S p. P376
artikel
1631 The MimoVax vaccine: A novel Alzheimer treatment strategy targeting truncated Aß40/42 by active immunization Mandler, Markus
2009
5 4S p. P114
artikel
1632 The molecular chaperone human Aβ crystallin modulates amyloid-β neurotoxicity Ghosh, Joy G.
2009
5 4S p. P304
artikel
1633 The Multidomain Alzheimer Preventive Trial (MAPT): A new approach for the prevention of Alzheimer's disease Gillette, Sophie
2009
5 4S p. P145
artikel
1634 The need for a new practical Alzheimer's disease scale Robert, Philippe
2009
5 4S p. P186
artikel
1635 The Neuronal 5-lipoxygenase Enzymatic Pathway as a Novel Endogenous Modulator of the Gamma-secretase Complex Pratico, Domenico
2009
5 4S p. e3
artikel
1636 The NIH toolbox for assessment of neurological and behavioral function Hendrie, Hugh C.
2009
5 4S p. P218
artikel
1637 The PARS/Mindspan Study: Enriching a population at risk for Alzheimer's disease Jennings, Danna
2009
5 4S p. P36
artikel
1638 The Passport Study, a multidomain lifestyle intervention to promote healthy brain aging Hanson, Leah R.
2009
5 4S p. P412-P413
artikel
1639 The pathogenic I716F amyloid precursor protein (APP) mutation leads to a reduced protein processing and a very aggressive early-onset Alzheimer's disease Guardia-Laguarta, Cristina
2009
5 4S p. P223
artikel
1640 The phenotype associated with the novel A152T mutation in MAPT exon 7 Kovacs, Gabor G.
2009
5 4S p. P297
artikel
1641 The Posterior Fluent Variant Of Primary Progressive Aphasia: A Case Report Caffarra, Paolo
2009
5 4S p. e8-e9
artikel
1642 The practice of gateball and mahjong among older adults of Japanese ascent residents in Brazil: Contributions of lifestyle to cognition Kanashiro, Miriam M.
2009
5 4S p. P412
artikel
1643 The prediction of cognitive decline in cognitive intact subjects using regional cerebral blood flow SPECT: A communty-based study Nemoto, Kiyotaka
2009
5 4S p. P199-P200
artikel
1644 The prediction of cognitive decline in cognitive intact subjects using regional cerebral blood flow SPECT: A communty-based study Nemoto, Kiyotaka
2009
5 4S p. P25
artikel
1645 The prevalence and impact of type 2 diabetes in mild cognitive impairment and Alzheimer's disease Hodges, Elise K.
2009
5 4S p. P459
artikel
1646 The profile of patients engaged in cognitive training at a memory clinic Olchik, Maira Rozenfeld
2009
5 4S p. P333-P334
artikel
1647 The prolonged high-fat dietary impairs functional neuronal insulin sensitivity in hippocampus Chattipakorn, Siriporn
2009
5 4S p. P172
artikel
1648 The Protective Effect of Chotosan(CTS) on Beta-Amyloid Protein-induced Apoptosis in PC12 Cells Yuanying, Liu
2009
5 4S p. e27
artikel
1649 The proteomic study of SAMP8 brain cultures reveals age-related alterations in neurons and astrocytes Sanfeliu, Coral
2009
5 4S p. P178
artikel
1650 The P2Y-like GPR17 receptor participates in oligodendrocyte precursor cell reaction in a model of chronic cerebral amyloidosis Boda, Enrica
2009
5 4S p. P490
artikel
1651 The relation among cardiovascular risk, MMSE and depressive symptoms in patients with cardiovascular risk at a university hospital Varela, Juliana S.
2009
5 4S p. P287-P288
artikel
1652 The relationship between brain ventricular volume and cerebrospinal fluid levels of A-beta and tau in apolipoprotein E4 positive normal controls and patients with Alzheimer's disease Ott, Brian R.
2009
5 4S p. P299-P300
artikel
1653 The relationship between education and older adults memory complaints Lee V. Paulo, Debora
2009
5 4S p. P61
artikel
1654 The relationship between education in older adults' memory complaints Paulo, Debora Lee V.
2009
5 4S p. P236
artikel
1655 The relevance of cholinergic-catecholaminergic interaction (cognitive processes and oxidative stress) in Alzheimer's disease Ciobica, Alin
2009
5 4S p. P67
artikel
1656 The relevance of cholinergic-catecholaminergic interaction (cognitive processes and oxidative stress) in Alzheimer's disease Ciobica, Alin
2009
5 4S p. P331
artikel
1657 The role for CSF dynabridging studies in developing new therapies for Alzheimer's disease Ereshefsky, Larry
2009
5 4S p. P414-P415
artikel
1658 The role of ApoE and ApoE receptors for synaptic dysfunction in Alzheimer's disease Herz, Joachim
2009
5 4S p. P168-P169
artikel
1659 The role of APP processing in oxidant-induced damage in cultured neuroblastoma cells Zheng, Lin
2009
5 4S p. P224-P225
artikel
1660 The role of autophagy in potentially therapeutic copper complexes Price, Katherine A.
2009
5 4S p. P414
artikel
1661 The role of ghrelin in the hippocampal neuron plasticity Isokawa, Masako
2009
5 4S p. P172
artikel
1662 The role of LRP as a competitive substrate of the APP for BACE1 Schwanzar, Daniel
2009
5 4S p. P495-P496
artikel
1663 The role of PIP2 phosphatase synaptojanin 1 in Alzheimer-linked synaptic and neurobehavioral dysfunction Di Paolo, Gilbert
2009
5 4S p. P70
artikel
1664 The Role of post-translational modification (phosphorylation) in modulating alpha-synuclein, structure, aggregation and toxicity Lashuel, Hilal A.
2009
5 4S p. P124-P125
artikel
1665 The role of S100a9 in the neuroinflammation of Alzheimer's disease transgenic mouse model, Tg2576 Chang, Keun-A
2009
5 4S p. P481
artikel
1666 The role of steroid sulfatase inhibition in rats with loss of septal-hippocampal cholinergic neurons: Effects on hippocampal muscarinic receptor function and alpha-secretase enzyme activity Pokala, Vedavalli N.
2009
5 4S p. P329
artikel
1667 The safety profile of ACI-24, an oligo-specific amyloid beta vaccine, demonstrated decrease of large microbleedings in brain of aged Alzheimer's disease mouse model Pihlgren, Maria
2009
5 4S p. P425-P426
artikel
1668 The scopolamine-induced deficit model is a viable translational approach that can expedite decision making in clinical development: Preclinical evidence Rueter, Lynne E.
2009
5 4S p. e29
artikel
1669 The short-term effect of acetylcholinesterase inhibitor on the regional cerebral blood flow of Alzheimer's disease Cho, Hyun
2009
5 4S p. P334
artikel
1670 The sortilin-related receptor (SORL1) influences variation in memory in late-onset Alzheimer disease Reitz, Christiane
2009
5 4S p. P464
artikel
1671 The sortilin-related receptor (SORL1) influences variation in memory in late-onset Alzheimer's disease Reitz, Christiane
2009
5 4S p. P468-P469
artikel
1672 The structural context of amyloidogenic sequences in native proteins Tzotzos, Susan J.
2009
5 4S p. P225
artikel
1673 The Structured Clinical Impression of Progressivity scale: Can we improve the success rate of Alzheimer's clinical trials by confirming progressivity? Babic, Tomislav
2009
5 4S p. P278
artikel
1674 The Swedish brain power multicenter study: CSF biomarker data report Mattson, Niklas
2009
5 4S p. P94
artikel
1675 The Sydney Memory and Ageing Study (MAS): A population-based longitudinal investigation of cognitive health in the elderly Kochan, Nicole
2009
5 4S p. P290-P291
artikel
1676 The syndrome of progressive posterior cortical dysfunction: A multiple case study Areza-Fegyveres, Renata
2009
5 4S p. P500
artikel
1677 The treatment compliance with rivastigmine patch in clinical practice versus trial data: A case series Hausner, Lucrezia
2009
5 4S p. P251
artikel
1678 The types of neuropsychological impairments present in MCI and dementia translate into similar types of deficits in everyday functioning Farias, Sarah Tomaszewski
2009
5 4S p. P450
artikel
1679 The usefulness of the IQCODE in a memory clinic setting Sikkes, Sietske A.M.
2009
5 4S p. P374-P375
artikel
1680 The use of honey as a natural preventive therapy of cognitive decline and dementia in the middle east Al-Himyari, Fizel A.
2009
5 4S p. P247
artikel
1681 The use of profanity during letter fluency tasks in frontotemporal dementia syndromes and Alzheimer's disease Ringman, John M.
2009
5 4S p. P458
artikel
1682 The use of proteinomics and metabolomics in epidemiology Grodstein, Francine
2009
5 4S p. P95
artikel
1683 The use of scales to measure function in global clinical Alzheimer's trials: How well do they translate? Farias, Sarah Tomaszewski
2009
5 4S p. P170
artikel
1684 The Validity and reliability of the Literacy Independent Cognitive Assessment (LICA) Han, Seol-Heui
2009
5 4S p. P131
artikel
1685 The zebrafish brain proteome project Abramsson, Alexandra V.
2009
5 4S p. P176
artikel
1686 Three dimensional structure of signal peptide peptidase Miyashita, Hiroyuki
2009
5 4S p. P317
artikel
1687 Time course of intra- and extracellular amyloidosis in a murine model of Alzheimer's disease Montarolo, Francesca
2009
5 4S p. P434
artikel
1688 Tocopherols And Tocotrienols Plasma Levels And The Risk Of Alzheimer's Disease In The Oldest Old: Results From The Kungsholmen Project Mangialasche, Francesca
2009
5 4S p. e12
artikel
1689 Tocotrienol attenuates diabetes associated cognitive deficits in rats Kuhad, Anurag
2009
5 4S p. P482
artikel
1690 Tocotrienol attenuates diabetes-associated cognitive deficits in rats Kuhad, Anurag
2009
5 4S p. P44
artikel
1691 Toll-like receptor 9 ligand CpG ODN as a new highly effective agent for prevention and/or treatment of Alzheimer's disease Scholtzova, Henrieta
2009
5 4S p. P137-P138
artikel
1692 Toward a multi-dimensional formulation of Alzheimer's disease pathogenesis and pathophysiology O. Kuljis, Rodrigo
2009
5 4S p. P275
artikel
1693 Toward a smart home solution for domiciliary assistance in Alzheimer's diseases Cavallo, Filippo
2009
5 4S p. P141
artikel
1694 Towards the treatment of Alzheimer's disease: Discovery and development of novel subtype-specific M1 allosteric agonists Lebois, Evan P.
2009
5 4S p. P335
artikel
1695 Toward the novel method of treatment for Alzheimer's disease: Extra-corporeal Aβ removal system (EARS) Kawaguchi, Kazunori
2009
5 4S p. P415
artikel
1696 Tracking disease progression with volumetric MRI Fox, Nick
2009
5 4S p. P3
artikel
1697 Training raters to participate in global Alzheimer's trials: How to achieve and maintain accurate ratings Miller, David S.
2009
5 4S p. P171
artikel
1698 Transgenic mice expressing APP intracellular domain recapitulate Alzheimer's disease pathological features Pimplikar, Sanjay W.
2009
5 4S p. P83
artikel
1699 Transgenic mice with the Arctic APP mutation show an age-dependent increase in Aβ levels Graff, Caroline
2009
5 4S p. P442
artikel
1700 Translating policy and practice: Learning between more developed and less developed regions McCabe, Louise
2009
5 4S p. P119
artikel
1701 Transmembrane domain of CRB2 is indispensable for inhibition of γ-secretase activity Nishimura, Masaki
2009
5 4S p. P226-P227
artikel
1702 Transmission of Alzheimer's disease by seeding and cross-seeding Soto, Claudio
2009
5 4S p. P115
artikel
1703 Transthyretin correlated with oxidative stress in Alzheimer's disease pathology: A population-based study (BERCAL) Gustaw, Katarzyna A.
2009
5 4S p. P352
artikel
1704 Treatment compliance with rivastigmine patch: Does a novel application form lead to enhanced adherence? Kurz, Alexander
2009
5 4S p. P185-P186
artikel
1705 Treatment effects of NSAIDs related to stage of Alzheimer pathogenesis: Lessons from ADAPT Breitner, John C.S.
2009
5 4S p. P144
artikel
1706 Treatment for patients and caregivers in the developing world Prince, Martin J.
2009
5 4S p. P117-P118
artikel
1707 Treatment of myoclonus in corticobasal degeneration by levetiracetam: Report of two cases Kovács, Tibor
2009
5 4S p. P502
artikel
1708 Treatment of paraphilic hypersexuality in dementia Tavares, Almir R.
2009
5 4S p. P243
artikel
1709 Trends in informal care in Sweden: Is it decreasing? Cross-sectional studies with the RUD instrument Wimo, Anders
2009
5 4S p. P410
artikel
1710 Trial for detection of Aβ-like peptides in peripheral blood Kodama, Takashi S.
2009
5 4S p. P345
artikel
1711 Truncation and activation of Dyrk1A in Alzheimer's disease brain by activated calpain I Liu, Fei
2009
5 4S p. P134-P135
artikel
1712 Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43 Nonaka, Takashi
2009
5 4S p. P174
artikel
1713 Twelve-Month follow-up study of Fractional Anisotropy changes in Mild Cognitive Impairment compared to healthy elderly subjects Likitjaroen, Yuttachai
2009
5 4S p. P5
artikel
1714 Twenty years change in cholesterol and risk of dementia Solomon, Alina
2009
5 4S p. P390
artikel
1715 TYM testing Brown, Jeremy M.
2009
5 4S p. P183
artikel
1716 Tym testing Brown, Jeremy M.
2009
5 4S p. e31
artikel
1717 Type 2 diabetes and incidence of dementia and cognitive decline: what are the mechanisms? Haan, Mary N.
2009
5 4S p. P123
artikel
1718 Ultrastructural investigation of tau-dependent dendropathy in a triple transgenic mouse model of Alzheimer's disease Hoffmann, Nadine A.
2009
5 4S p. P396-P397
artikel
1719 Uncontrolled diabetes increases risk for Alzheimer disease: A population-based cohort study Xu, Weili
2009
5 4S p. P127-P128
artikel
1720 Updated cost-effectiveness projections for donepezil in the treatment of patients with mild-to-moderately severe Alzheimer's disease in the UK Maclaine, Grant
2009
5 4S p. P409
artikel
1721 Urea cycle and Alzheimer's disease Hansmannel, Franck
2009
5 4S p. P461
artikel
1722 Use of an antibody-coupled array and mass spectrometry for simultaneous detection of multiple amyloid beta fragments Bulman, Amanda L.
2009
5 4S p. P348
artikel
1723 Use of a wild-type tauopathy model to generate a novel Alzheimer model Adams, Stephanie J.
2009
5 4S p. P445
artikel
1724 Use of MRI in epidemiological studies Launer, Lenore
2009
5 4S p. P96
artikel
1725 Use of neuroimaging in preventive trials Nestor, Peter J.
2009
5 4S p. P144
artikel
1726 Using high density event-related potentials to study recognition memory in pre-symptomatic individuals with familial Alzheimer's disease due to E280A presenilin-1 mutation Quiroz, Yakeel T.
2009
5 4S p. P199
artikel
1727 Using high density event-related potentials to study recognition memory in presymptomatic individuals with familial Alzheimer's disease due to E280A presenilin-1 mutation Quiroz, Yakeel T.
2009
5 4S p. P23-P24
artikel
1728 Using regression and classification trees to examine dementia risk as a predictor of cognitive function in healthy middle-aged adults with a family history of Alzheimer's disease Dowling, Maritza
2009
5 4S p. P279
artikel
1729 Utility of hypercapnic ventilation response for the diagnosis of DLB with depression as the initial symptom: A prospective study Takahashi, Sho
2009
5 4S p. P356
artikel
1730 Vaccination with Abeta displaying virus-like particles reduces soluble and insoluble cerebral Abeta and lowers plaque burden in APP transgenic mice Mueller, Ulrike
2009
5 4S p. P418-P419
artikel
1731 Val(8)GLP-1, a protease-resistant incretin analogue, prevents the impairment of hippocampal synaptic plasticity in an APP/PS-1 mouse model of Alzheimer's disease Holscher, Christian
2009
5 4S p. P325
artikel
1732 Validity of functional independence measure for patients with Alzheimer's disease and vascular dementia Suzuki, Keiji
2009
5 4S p. P191
artikel
1733 Variable association between use of NSAIDs and risk of AD in different samples: Does the disparity in results reflect the different age distributions of the participants? Breitner, John C.S.
2009
5 4S p. P285
artikel
1734 Various lengths of C-terminal fragments of amyloid precursor protein induce neurotoxicity, not only C31 Choi, Yoori
2009
5 4S p. P310
artikel
1735 Vascular dementia, an avoidable disease, may be much more common than presumed: A postmortem study in a large population-based series Grinberg, Lea T.
2009
5 4S p. P164
artikel
1736 Vascular risk factors are associated with a reduced brain volume: The mayo clinic study of aging Roberts, Rosebud O.
2009
5 4S p. P296
artikel
1737 Verbal fluency and physical activity in the aging process: An epidemiological study carried out in São Paulo, Brazil da Silva, Thais B.L.
2009
5 4S p. P291
artikel
1738 Vigilance: A core feature of caregiver burden in dementia Bourgeois, Julie
2009
5 4S p. P91
artikel
1739 Viral APP/tau transgene delivery models degenerative events in hippocampal neurones Stoppelkamp, Sandra
2009
5 4S p. P432-P433
artikel
1740 Visual impairment in posterior cortical atrophy and dementia with lewy bodies Metzler-Baddeley, Claudia
2009
5 4S p. P458
artikel
1741 Visual memory in V2 visual cortex: An animal model aproach Lopez-Aranda, Manuel F.
2009
5 4S p. P175-P176
artikel
1742 Visuoconstructional creative performance as an indicator of general cognitive abilities in normal elderly Bartos, Ales
2009
5 4S p. P449
artikel
1743 Visuospatial memory training in patients with Alzheimer's dementia Adler, Georg
2009
5 4S p. P411
artikel
1744 Volumetric, cortical thickness and grey matter density changes on MRI over 12 months: Relationship to conversion status in the ADNI cohort Risacher, Shannon L.
2009
5 4S p. P26-P27
artikel
1745 Volumetric, cortical thickness and grey matter density changes on MRI over 12 months: Relationship to conversion status in the ADNI cohort Risacher, Shannon L.
2009
5 4S p. P200
artikel
1746 Volumetric measurement versus visual rating system of MRI for the diagnosis of Alzheimer's disease Shen, Qian
2009
5 4S p. P216-P217
artikel
1747 Volumetric measurement versus Visual rating system of MRI for the diagnosis of Alzheimer's disease Shen, Qian
2009
5 4S p. P53
artikel
1748 Voluntary exercise ameliorates both cognitive and noncognitive symptoms in the 3xTgAD mouse García, Yoelvis
2009
5 4S p. P443
artikel
1749 Voting and proxy voting appointment capacities in internal medicine inpatients and two populations of geriatric subjects Bosquet, Antoine
2009
5 4S p. P141
artikel
1750 Voxel-based morphometry of amnestic mild cognitive impairment and Alzheimer's disease He, Yi
2009
5 4S p. P12-P13
artikel
1751 Voxel-based morphometry of amnestic mild cognitive impairment and Alzheimer's disease He, Yi
2009
5 4S p. P359
artikel
1752 Voxel-based morphometry study of gray matter abnormalities in neurodegenerative disease with obsessive-compulsive behaviors Lee, Kang Joon
2009
5 4S p. P213-P214
artikel
1753 Web-based application to estimate and project the burden of Alzheimer's disease and evaluate the impact of potential interventions Colantuoni, Elizabeth
2009
5 4S p. P281
artikel
1754 39-week toxicity and toxicokinetic study of PF-04360365 in cynomolgus monkeys with 12-week recovery period Freeman, Gary B.
2009
5 4S p. P423
artikel
1755 Wernicke's aphasia caused by Broca's area infarction: A PET follow-up study Roh, Jee Hoon
2009
5 4S p. P201-P202
artikel
1756 Wernicke's aphasia caused by Broca's area infarction: a PET follow-up study Roh, Jee Hoon
2009
5 4S p. P29-P30
artikel
1757 White Matter Imaging in Understanding Aging and Alzheimer's Disease DeCarli, Charles
2009
5 4S p. P2
artikel
1758 Whole genome association strategies in Alzheimer's disease Riemenschneider, Matthias
2009
5 4S p. P169
artikel
1759 Why Alzheimer patients and caregivers participate in randomized clinical trials Akenine, Ulrika
2009
5 4S p. P97
artikel
1760 Why is the aging brain predisposed to Alzheimer disease and how do we reverse it? Brewer, Gregory J.
2009
5 4S p. P313
artikel
1761 Will Neuroimaging help us understand Alzheimer's disease? Jagust, William
2009
5 4S p. P1
artikel
1762 Withdrawn 2009
5 4S p. P297
artikel
1763 WWW.Demenz-Leitlinie.De - A free online access to e-guidelines on dementia and knowledge transfer for health providers, family members and patients Komarahadi, Fely
2009
5 4S p. P241-P242
artikel
1764 X chromosome premature centromere division in neurons of Alzheimer patients Spremo-Potparevic, Biljana
2009
5 4S p. P485
artikel
                             1764 gevonden resultaten
 
<< vorige   
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland